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ABSTRACT 
Intermediate filaments (IFs), a major constituent of the cellular cytoskeleton, 
contribute mainly to the mechanical stability of the cell. Simple epithelial keratins 
(SEKs) are IF proteins expressed in the single-layered and glandular epithelia of 
organs that involve secretion and absorption. In the colon, the main keratins (K) 
expressed are K7, K8, K18, K19 and K20. A new emerging role of SEKs in stress 
protection has been described for epithelial organs such as the liver, pancreas and 
kidney, where also the phosphorylation of K8 has been used as a marker of stress.  
The role of K8 in intestinal stress protection was examined by studying the stress 
response of the K8 wild type (K8+/+), K8 heterozygous (K8+/-) and K8 knock out 
(K8-/-) mice. K8+/+ mice were subjected to human disease-related stresses, while 
K8+/- mice were examined in regards of stress protection by investigating their 
stress susceptibility to colitis. The stress response in K8-/- mice was studied by 
investigating their impaired energy metabolism in response to ketogenic situations. 
As demonstrated by murine intestinal stress models, colonic keratins act as stress-
responsive proteins, which are upregulated in stress and recovery. Depletion of the in 
vivo colonic microbiota upregulated protein levels of the main colonic keratin-pair, 
K8-K19, confirmed by the lipopolysaccharide (LPS)-mediated in vitro inflammational 
stress model. Another inflammational stress-induced keratin pair identified was the 
K7-K20 pair, upregulated by the experimental dextran sulphate sodium (DSS) colitis 
model. Except for the K7-K20 upregulation on protein level, this stress model also 
affected the keratin distribution by showing a wider crypt distribution of both K7 and 
K20 in response to stress. The role of keratins in colonic stress protection was 
confirmed by examining the stress susceptibility of the K8+/- mouse. The K8+/- mouse, 
which has 50 % less K8 compared to the K8+/+ mouse, displays hyperproliferation, 
longer crypts and a higher susceptibility to DSS-induced colitis when compared to 
K8+/+ mice, suggesting a protective role for K8 in colonic stress. In addition, by 
examining the K8-/- mouse in regards of stress protection, the role of K8 in colonic 
energy homeostasis was investigated. K8 was found to modulate the energy 
metabolism in colonocytes by affecting the amount of the ketogenic control enzyme, 
3-hydroxy-3-methylglutaryl-CoA-synthase (HMGCS2). As a consequence of the 
deletion of K8 filaments, murine HMGCS2 levels were downregulted in the K8-/- 
mouse, together with the downregulation of the upstream short chain fatty acid 
(SCFA) transporter, monocarboxylate transporter isoform 1 (MCT1). Therefore, 
elevated K8-/- colonocyte luminal SCFAs that feed into the ketogenic pathway cannot 
enter the K8-/- colonocytes in sufficient amounts, leading to a decreased ketogenesis 
and overall ketogenic energy metabolism, contributing to the inflammatory K8-/- 
phenotype. When the impaired K8-/- ketogenesis was challenged with ketogenic 
conditions, the K8-/- mouse showed a blunted response, suggesting a protective role of 
K8 in the overall decreased K8-/- energy metabolism.  
In conclusion, these data, as shown by the K8+/+ stress-responsive behavior, the 
increased DSS-susceptibility of the K8+/- mice and the blunted K8-/- ketogenesis, 
indicate that colonic keratins likely play an important role in the protection from 
intestinal stress. 
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SWEDISH SUMMARY/SVENSK SAMMANFATTNING 
Keratin (K) intermediärfilament (IF) är cytoskelettstrukturer i epitelceller som 
skyddar cellen från mekanisk och icke-mekanisk stress. Mutationer i gener som 
kodar för keratiner leder till flera svåra sjukdomar i bland annat huden, levern och 
möjligtvis tarmen (Omary 2009). K7, K8, K18, K19 och K20 är enkla 
epitelkeratiner (eng. simple spithelial keratins, SEK) och de är de vanligast 
förekommande keratinerna i tjocktarmens enkla epitelvävnad. De indelas i typ I 
och typ II keratiner som bildar heteropolymera filament med varandra (Moll, Divo 
& Langbein 2008). Möss utan K8 (K8-/-) utvecklar diarré, ökad proliferation av 
tarmepitelceller samt en kronisk inflammation som liknar den som ses vid 
sjukdomarna ulcerativ kolit (eng. Ulcerative colitis, UC) och Crohns sjukdom (eng. 
Crohn’s disease, CD) (Baribault et al. 1994, Habtezion et al. 2005). Det är känt 
sedan tidigare att keratin- och intermediärfilamentnivåer ökar vid stress (Toivola et 
al. 2010) i lever (Guldiken et al. 2015a), bukspottskörtel (Zhong et al. 2004), njure 
(Djudjaj et al. 2016), lunga (Sivaramakrishnan et al. 2009) och hud (Jin, Wang 
2014), samt att keratinerna är reglerade av posttranslationella modifikationer vid 
stress (Snider 2016). Regleringen av gentranskriptionen av keratinerna i 
tjocktarmen är relativt okänd, även om man vet att transkriptionsfaktorn p53 
deltar i transkriptionen för K8 (Mukhopadhyay, Roth 1996) och att 
transkriptionsfaktorn AP1 deltar i transkriptionen för K18 (Gunther et al. 1995).  
Hypotesen för detta arbete var att tjocktarmens keratiner har en skyddande roll 
mot tarmpåfrestningar samt att de skyddar mot inflammatoriska tarmsjukdomar. 
De specifika målsättningarna var (1) att undersöka tjocktarmens keratinnivåer och 
-modifikationer under olika stress- och återhämtningstillstånd i tjocktarmen hos 
K8 vildtyps (K8+/+) möss, (2) att undersöka med hjälp av K8 heterozygot (K8+/-) 
musen om keratinerna bidrar till skyddandet mot tarmstress och (3) att undersöka 
keratinernas roll i tjocktarmens inflammatoriska energimetabolism med hjälp av 
K8-/- musen.  
I det första delprojektet undersöktes tjocktarmens keratiner i fråga om deras nivåer 
och modifikationer under olika stresstillstånd i tarmen. I många andra organ 
såsom levern, bukspottskörteln, njurarna, lungorna och huden har keratinerna 
visats vara uppreglerade till följd av stress på samma sätt som andra kända 
stressproteiner. Denna uppreglering till följd av stress kunde också påvisas i 
tjocktarmen, där specifika keratinpar uppreglerades av olika stressmodeller. 
Keratinparet K8-K19 visade en uppreglering i möss då de skyddande 
tarmbakterierna avlägsnades med hjälp av en antibiotikabehandling, vilket även 
kunde konfirmeras med hjälp av aktiveringen av inflammatoriska 
signalleringsräckor med en lipopolysackarid (LPS) behandling på humana 
tjocktarmscancerceller. Det andra stress-känsliga keratinparet, K7-K20, 
uppreglerades till följd av dextran sulfat natrium (eng. Dextran sulphate sodium, 
DSS)-inducerad experimentell tarminflammation. K7, som basalt befinner sig i 
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bottnet på tarmkryptorna, och K20, som basalt befinner sig i toppen på 
tarmkryptorna, uppvisade till följd av en kronisk DSS-behandling förutom en 
uppreglering, även en bredare distribution, med det stress-responsiva området i 
mittersta delen av tarmkryptan. Förutom denna uppreglering av tarmkeratinerna 
till följd av olika stressmodeller, sågs en ökning i fosforyleringen av K8 vid 
aminosyran Serin 74 (S74), vilken kunde användas som en markör för tarmstress i 
fortsatta studier (Publikation I).   
I det andra delprojektet undersöktes hur keratinerna bidrar till skyddandet mot 
tarmstress och upprätthållandet av tarmhälsan genom att analysera 
keratinnivåerna hos K8+/- musen. Resultaten visade att K8+/- musen uppvisar en 
mellanform av fenotyperna K8-/- och K8+/+ gällande keratin-mängder, krypt-längd 
och Na/Cl transport. Dessutom hade K8+/- mössen ett högre 
sjukdomsaktivitetsindex samt en långsammare återhämtning efter en DSS- 
behandling jämfört med K8+/+ musen, vilket antyder att K8+/- mössen är mera 
känsliga för DSS-inducerad kolit och att mängden keratiner är avgörande vid 
skyddandet mot tarmens påfrestningar (Publikation II). 
I det sista delprojektet undersöktes keratinernas roll i regleringen av 
energimetabolismen och ketogenesen i utvecklingen av det inflammatoriska 
tillståndet i tjocktarmens epitelceller hos K8-/- musen. De keratin-specifika 
skillnaderna undersöktes genom att kartlägga K8-/- musens största 
proteinskillnader i tjocktarmen jämfört med K8+/+ musen. Den största upptäckten 
var att enzymet 3-hydroxy-metylglutatyl CoA syntas 2 (eng. 3-hydroxy-
methylglutatyl CoA synthase 2, HMGCS2), som reglerar ketogenesen, var kraftigt 
nedreglerat i tjocktarmen hos möss som saknar K8. Förutom en minskad mängd 
HMGCS2, uppmättes även en minskad aktivitet hos ifrågavarande enzym. 
Energimetabolismen och bakterieförhållanderna i tjocktarmarna på dessa möss 
studerades också för att få en större klarhet i det inflammatoriska tillståndet. 
Förutom en nedreglering av enzymet HMGCS2, visades även att 
butyrattransportören monokarboxylat transportör 1 (eng. monocarboxylate 
transporter 1, MCT1) var nedreglerad. Butyrat, en kortkedjad fettsyra (eng. short 
chain fatty acid, SCFA) som produceras av de godartade bakterierna i tarmen, är 
den huvudsakliga energikällan för epitelcellerna i tjocktarmen. Hypotesen testades 
genom att utsätta K8-/- möss för ketogena förhållanden, varvid resultaten visade att 
HMGCS2 inte uppregleras i samma proportion hos K8-/- möss som hos K8+/+ möss, 
vilket sannolikt bidrar till den inflammatoriska K8-/- fenotypen och antyder att K8 
har en skyddande roll även i mekanismer relaterade till energimetabolismen 
(Publikation III).  
Sammanfattningsvis påvisar denna avhandling keratinernas skyddande roll i 
tjocktarmen genom att keratinerna uppregleras till följd av inducerad stress, vilket 
stöds av att nedsatta K8 nivåer förorsakar en ökad känslighet till tarmsjukdom.   
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Introduction 
1 
INTRODUCTION 
In all living cells of the human body, a cytoskeleton contributes to the molecular 
structure of the cells. The main functions of the cytoskeleton, which consists of 
actin filaments, microtubules and IFs, are to provide mechanical strength and 
shape to the cell, separate chromosomes in cell division, provide a scaffold in 
cellular organization and take part in signaling cascades inside the cells. Many 
functions have likely not been discovered yet, especially regarding the IFs of the 
cytoskeleton although many emerging roles of IFs are described by the disease 
phenotypes linked to them. So far, no diseases coupled to mutations in genes 
coding for actin filaments or microtubules have been described, in contrary to IFs, 
which display a connection to more than 80 human diseases. 
SEKs are IFs expressed in the single-layered and glandular epithelia, in organs that 
involve secretion and absorption. SEKs are present in many different cell types in 
the colon, from nutrient-absorptive enterocytes and hormone-secreting 
enteroendocrine cells to cells with specialized tasks such as mucus-secreting goblet 
cells. In these cells different cellular processes are likely dependent on the SEKs 
present.  
The inner layers of the colon facing the intestinal lumen are highly exposed to 
outer influences, giving the single-layered epithelium of the colon extra challenges 
besides of the constant functions in nutrient processing. A newly emerging role of 
the intestinal microbiota has been suggested for intestinal health.  
For analyzing the specific roles of colonic SEKs, specific transgenic mouse models 
and cell lines were used. In this thesis, the colonic model systems were challenged 
with different stress conditions, where after the outcome was studied in regards 
keratins and their colonic functions. 
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REVIEW OF THE LITERATURE 
1. Cytoskeleton and intermediate filaments 
The cytoskeleton, which contributes to the mechanical integrity of the cell, can be 
found all over the cell. Apart from mechanical functions, the cytoskeleton has 
functions in the regulation, migration, division, transport and signaling of cells 
(Kim, Coulombe 2010). Besides microtubules and actin filaments, the cytoskeleton 
consists of IFs with an intermediate diameter of 10 nm compared to the small 7 nm 
actin filaments and the larger 25 nm microtubules. Except for the distinct role of 
IFs in cell structure and as stress mediators, the role of IF proteins has recently 
been extended to function as signaling and regulatory proteins (Herrmann et al. 
2007, Pallari, Eriksson 2006, Toivola et al. 2005). Another difference between these 
three cytoskeletal elements is in the polymerization of the proteins. In contrast to 
microtubules and actin filaments, IFs are non-polar filaments where the assembly 
and the depolymerization is not restricted to a specific end of the filament (Koster 
et al. 2015). 
While microtubules and actin filaments mainly consist of tubulin and actin 
respectively, the family of IFs consists of proteins encoded by more than 70 
different genes (Hesse, Magin & Weber 2001, Herrmann et al. 2007). IFs are 
involved in the cause or in the predisposition to disease in more than 80 human 
diseases, by a predisposition, a mutation or by inclusion-formation associated to IF 
overexpression (Omary 2009). The classification, tissue distribution and related 
diseases of IF proteins can be seen in Table 1.  
Table 1. IF-proteins, their tissue-distribution and related human diseases. Table created based 
on (Eriksson et al. 2009, Omary 2009, Szeverenyi et al. 2008, Omary, Coulombe & McLean 2004). 
IF type Protein Distribution Related disease 
Type I Acidic keratins Epithelial cells Skin, nail, hair, liver 
disorders 
Type II Basic and neutral keratins Epithelial cells Skin, nail, hair, liver 
disorders 
Type III Vimentin Mesenchymal cells, lens Cataract 
 Desmin Muscle cells Cardiomyopathies 
 Syncoilin Muscle cells Muscular dystrophy 
 Peripherin Peripheral nervous system ALS 
 GFAP Astrocytes Alexander disease 
Type IV Neurofilaments Central nervous system ALS, CMT, Parkinson’s 
disease 
 Internexin Central nervous system - 
 Nestin Neuroepithelial cells - 
 Synemin Muscle cells - 
Type V Lamins Nuclear lamina, all cells HGPS 
Type VI Bfsp1 Fiber cells, lens Cataract 
 Bfsp2 Fiber cells, lens Cataract 
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Besides other types of post-translational modifications (PTM), such as 
glycosylation, acetylation, farnesylation and ubiquitylation, IFs are highly 
phosphorylated in response to apoptosis, mitosis and stress, leading to a non-
filamentous and soluble form (Snider, Omary 2014, Snider, Omary 2016). For 
example in liver (Fickert et al. 2003, Toivola et al. 2004b) and the central nervous 
system (Ackerley et al. 2004), IF hyperphosphorylation serves as a marker and 
protector of tissue injury. 
1.1 Simple epithelial keratins 
The keratin subfamily of IFs consists of proteins coded by 54 functional genes 
clustered on two chromosomal sites; type I keratins on chromosome 17q21.2 and 
type II keratins on chromosome 12q13.13 (Schweizer et al. 2006). Keratins are 
divided into type I and type II keratins, which form obligate heteropolymers with 
each other and they are expressed in a tissue and/or cell-specific manner  (Moll, 
Divo & Langbein 2008).  
K7, K8, K18, K19 and K20 are SEKs, which are expressed in polarized (Oriolo et al. 
2007), single-layered and glandular epithelia, in organs involving secretion and 
absorption. The primary and most studied SEK pair is K8/K18. In many cells, such 
as in hepatocytes and in renal tubular cells, K8/K18 is the only existing keratin-pair, 
while in intestinal epithelial cells, duct-lining cells, mesothelial cells and in urothelial 
cells other SEKs are also expressed (Moll, Divo & Langbein 2008, Omary et al. 2009). 
Other described SEKs are K7, K19, K20 and K23. K7 and K19 are commonly 
expressed in ductal epithelia, such as in bile ducts and in pancreatic ducts. K20, 
expressed in intestinal, gastric foveolar and urothelial epithelium (Moll, Divo & 
Langbein 2008), is used as an immunohistochemical marker of tumorigenesis, since 
it is expressed in primary and metastatic carcinomas (Moll et al. 1992). The less 
abundant and not yet well-characterized SEK, K23, is basally expressed in 
gallbladder and bile ducts, and in smaller amounts in liver and colon (Guldiken et al. 
2016). It is also expressed during the differentiation of pancreatic (Zhang et al. 2001) 
and colorectal (Liffers et al. 2011) cancer cells. Beyond SEK, keratins in stratified 
epithelium are expressed in e.g skin (K2, K5-K6, K9, K14-K16) (Wang, Zieman & 
Coulombe 2016)  and hair (K31-K40, K81-K86) (Schweizer et al. 2007). 
1.1.1 Simple epithelial keratin function 
The proteins in the keratin family are highly cell type-specifically expressed, and 
inside the cell they can be found all the way from the nucleus, passing through the 
cytoplasm, to the cell membrane where they contribute to the cell-cell junctions in 
desmosomes. This suggests that SEKs play a central role in the mechanical stability 
and integrity of the cell. Apart from the structural stability, SEKs function as stress 
protectors (Toivola et al. 2010). SEKs share similar features with other known 
stress proteins, such as for example heat shock proteins (HSPs), in regards of 
upregulation of mRNA and/or protein levels in stress and in recovery from stress. 
The absence or lowered levels of SEKs cause injury or susceptibility to injury, 
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further confirming the role of SEKs as stress protectors. How this is done is likely 
SEK- and tissue-specific, but evidence of providing mechanical support, acting as 
protein scaffolds, serving as anti-apoptotic proteins and/or providing a phosphate 
buffer has been proposed (Toivola et al. 2010). SEKs are mostly anti-apoptotic and 
protect from Fas-mediated apoptosis. In mice, K8-/- hepatocytes are more sensitive 
to apoptosis (Tao et al. 2009, Gilbert et al. 2001), while K8-/- colonocytes show a 
microbiota-dependent resistance to apoptosis (Habtezion et al. 2011). The role of 
SEKs in the regulation of cellular organelles has been demonstrated by models 
where SEK networks have been modified, e.g. mitochondria in liver hepatocytes are 
smaller and irregularly distributed in mice that lack K8 (Tao et al. 2009). The role 
of SEKs in targeting cellular proteins to their aimed positions has been described 
both for colonocyte ENaC (Toivola et al. 2004a) and hepatocyte ecto-ATPase 
(Satoh, Hovington & Cadrin 1999). The chloride transporter downregulated in 
adenoma (DRA) is dramatically downregulated in K8-/- mice when compared to 
K8+/+ mice, even if it was not mistargeted (Asghar et al. 2016). Disturbances in 
protein localization due to SEK modifications have also been reported using the 
K18 Arginine (R) 90 Cysteine (C) mutant cell line, where the proteins desmoplakin 
and zonula occludens-1 were relocated to keratin inclusions (Hanada et al. 2007). 
SEKs also display an important role in functioning as signaling platforms, for 
example by acting as scaffolds and binding the adapter protein 14-3-3, which 
regulates the activity of many downstream signaling proteins (Ku et al. 2002, 
Pallari, Eriksson 2006). Recently, the existence of nuclear keratins and their direct 
role in cell proliferation and gene expression of cancer cells has been suggested 
(Hobbs, Jacob & Coulombe 2016). Studies focused on nuclei of skin and cervical 
tumor cells indicate active roles of K17 in gene expression and cell cycle regulation 
(Hobbs, Jacob & Coulombe 2016) . 
1.1.2 Simple epithelial keratin structure 
SEKs are obligate heteropolymers, meaning that one type I and one type II keratin 
form pairs with each other. The common structure of all SEKs is a central coiled-
coil α-helical rod domain with a non-α-helical N-terminal head and C-terminal tail 
domain (Fig. 1) (Omary et al. 2009). The rod domain is highly conserved between 
all SEKs and it is divided into three subdomains, 1A, 1B and 2, which are linked 
together by two linkers, L1 and L12 (Omary et al. 2009). The tail domains of the 
different SEKs are somewhat different in length, for example K19 has a 13-amino 
acid long tail while the tail of K8 is 85-amino acid long. In spite of the varying 
length, the head and tail domains include the most commonly known sites for 
PTMs (Omary et al. 2006). For example, K8 phosphorylation in the head domain 
occurs mainly on the amino acid Serine (S) 24 (Ku, Omary 1997) and S74 (Liao, Ku 
& Omary 1997) and K8 phosphorylation on the tail domain occurs on S432 (Ku, 
Omary 1997). All known phosphorylation sites of SEKs are described in Figure 1.  
SEK type I-type II heterodimers form tetramers that are assembled to form unit 
length filaments (ULF)s. Eight ULFs are further assembled longitudinally, forming 
mature keratin filaments with a diameter of 10 nm (Herrmann et al. 2009). 
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Figure 1. Structure and known phosphorylation sites of SEKs. SEKs consist of a central coiled-
coil α-helical rod domain (consisting of subdomains 1A, 1B and 2, linked together by two linkers, 
L1 and L12) with a non-α-helical N-terminal head domain and C-terminal tail domain. Known 
SEK phosphorylation sites are described for K8 (Liao, Ku & Omary 1997, Ku, Omary 1997), K18 
(Ku, Omary 1994, Ku, Liao & Omary 1998), K19 (Zhou et al. 2010, Zhou et al. 1999) and K20 
(Zhou et al. 2006). 
1.1.3 Simple epithelial keratin regulation 
1.1.3.1 Transcriptional regulation 
Although it is known that keratins are extensively regulated at transcriptional level, 
the exact mechanism of how this is done is not well understood. No universal 
regulators of all SEKs have been found, and therefore it is thought that the 
expression of all SEKs have their own specific transcription mechanism including 
their own set of transcription factors and promoter regions.  
The mechanisms on transcriptional regulation of K18 are the most extensively 
studied of all SEKs. The promoter, the regulatory sites and the enhancer of 
transcription have been mapped for the K18 gene (Prochasson et al. 1999). 
Transcription factors shown to be involved in the regulation of K18 transcription 
are Specificity protein 1 (SP1) (Gunther et al. 1995), Activator protein-1 (AP-
1)(Rhodes, Oshima 1998), CREB-binding protein/p300 (CBP/p300) (Prochasson et 
al. 1999) and E26 transformation-specific (ETS) (Pankov et al. 1994). However, 
other mechanisms have also been shown to influence the gene transcription of K18, 
e.g. the acetylation state of the transcription factors binding the promoter enhances 
K18 gene transcription (Gunther et al. 1995), while DNA methylation represses the 
transcription of the K18 gene (Umezawa et al. 1997).  
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The transcriptional regulation of K8 is not as extensively studied as the gene 
transcription of K18. K8 expression is regulated by the binding of tumor 
suppressor protein p53 (p53) to the 5’ region of the K8 gene. Deletion of this p53-
binding region abolished K8 activation, suggesting that the expression of K8 is 
regulated by p53 binding (Mukhopadhyay, Roth 1996). Similarly, transcription 
factors ETS1 and ETS2 have been shown to be involved in the regulation of K8 
gene expression by binding to the enhancer of the K8 gene at the 3’ region, which 
contains binding sites for ETS (Mukhopadhyay, Roth 1996, Takemoto et al. 1991). 
Except for K8 and K18, the transcriptional regulation of K19 has been studied to 
some extent. Regulatory elements on the K19 gene have been identified (Hu, Gudas 
1994), and transcription factors Kruppel-like factor 4 (KLF4) and SP1 are known to 
bind these sites (Brembeck, Rustgi 2000).  
1.1.3.2 Post-translational modifications 
PTMs occurring on the highly dynamic SEKs in response to stress, mitosis or 
apoptosis are phosphorylation, glycosylation, sumoylation and acetylation. The 
best-studied PTM of SEKs is phosphorylation, which maintains the structural 
keratin dynamics by regulating the assembly and disassembly of keratin filaments, 
and therefore regulating the solubility (Omary et al. 2006, Izawa, Inagaki 2006, 
Snider, Omary 2014). During baseline conditions, 95% of all SEKs are in an 
insoluble filamentous form, meaning that only 5% of the soluble SEKs are 
continuously hyperphosphorylated. In response to stress, mitosis or apoptosis, 
SEKs are phosphorylated. This phosphorylation serves as a protecting phosphate 
“sponge”, binding phosphate from other phosphate-activated proteins (Omary et 
al. 2006). The SEK phosphorylation sites are found in the head and tail domains, 
mostly at serine residues (Fig. 1). Phophorylation of K8 is modulated by stress-
activated protein kinases (Table 2), for example by protein kinase C (PKC)(Omary 
et al. 1998) c-Jun N-terminal kinase (JNK) (He et al. 2002), p38 mitogen-activated 
protein kinase (p38 MAPK) (Ku, Azhar & Omary 2002) and PKCδ (Ridge et al. 
2005). Rapidly accelerated fibrosarcoma-1 (Raf-1) has been described as a K18 
phosphorylation kinase (Ku, Fu & Omary 2004) Protein phosphatase 2A (PP2A) 
has been described as a phosphatase for K8 (Tao et al. 2006).  
Table 2. Selected SEK kinases. Description of SEK kinases, their site of action and associated 
event indicate that SEKs are mostly phosphorylated in stress, mitosis and/or apoptosis. 
SEK Site Kinase When Ref. 
K8 S74 JNK Stress, mitosis, apoptosis (He et al. 2002) 
K8 S74 p38 Stress, mitosis, apoptosis (Ku, Azhar & Omary 2002)  
K8 S432 MAPK, Cdc2 EGF stimulation, mitosis (Ku, Omary 1997) 
K8 S24 MAPK Stess, mitosis (Ku, Omary 1997) 
K18 S53 CAM, S6, PKCδ Stress, mitosis (Ku, Omary 1994) 
K19 ST391 Src Stress (Zhou et al. 2010) 
K20 S13 PKCδ Stress, apoptosis (Zhou et al. 2006) 
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In regards of glycosylation, K8 and K18 are the most studied keratins. They are 
glycosylated by O-linked glycosylation, where β-N-acetylglucosamine is added to 
serine/threonine residues. K18 is known to be glycosylated at S30, S31 and S49 in 
the head domain, and the major role of this PTM is to facilitate the 
phosphorylation kinases in response to cellular stress and injury (Ku et al. 2010, 
Chou, Smith & Omary 1992). K8, K18 and K19 can also be post-translationally 
modified by sumoylation, where a small ubiquitin-like modifier (SUMO) is 
covalently attached to lysine residues. During baseline conditions, SEKs are not 
sumoylated, but an increase in sumoylation can be seen in response to oxidative 
and apoptotic stress or during hyperphosphorylation seen in human liver disease 
(Snider et al. 2011). Another PTM regulating SEK function is acetylation. Except 
for modifying histones as a transcriptional control site, post-translational 
acetylation is known to regulate K8 function by reducing the solubility of K8 and 
forming filamentous keratin networks. Basally K8 is acetylated at several identified 
lysine residues (Leech et al. 2008), which promotes K8 filament stabilization. 
Increased K8 acetylation at Lysine 208 has been observed during hyperglycemia 
(Snider et al. 2013) and in response to butyrate treatment (Drake et al. 2009).  
1.2 Genetic mouse models of simple epithelial keratins 
Genetic mouse models have been proven very important in determining the roles 
of SEKs. A selection of generated mouse models are described here, divided in 
knockout (KO) mouse models (Table 2) and transgenic (TG) mouse models (Table 
3), which are further classified into WT overexpressor and SEK variant 
overexpressor mice.  
1.2.1 Knock out mouse models 
The functions of SEKs are demonstrated by the SEK knock out mouse models 
(Table 3). The first described SEK knock out mouse was the K8-/- mouse generated 
in the C57Bl/6 background (Baribault et al. 1993). Displaying a 95% embryonic 
lethality, an extensively studied knock out was created in the FVB/n background 
with only 50% embryonic lethality (Baribault et al. 1994). This model displays a 
hepatic, colonic and pancreatic phenotype, including mild hepatitis, increased 
susceptibility to liver injury (Ku et al. 2007), colorectal hyperproliferation, a TH2-
type colitis (Habtezion et al. 2005), impaired protein targeting (Toivola et al. 2004a, 
Asghar et al. 2016) and abnormal insulin and glucose metabolism (Alam et al. 
2013). 
Contrary to the K8-/- mouse, the K18-/- mouse does not develop embryonic lethality 
or a major intestinal phenotype, likely due to the compensatory role of the other 
co-existing type I keratin K19 (Magin et al. 1998). When both K18 and K19 are 
deleted, early embryonic lethality is observed, supporting the role of K19 as a 
compensatory keratin for K18 (Hesse et al. 2000). Other knock out models that 
display high embryonic lethality are the K type I-/- and K type II-/- mice, which lack 
all type I and type II keratins respectively. K type I-/- mice die at birth due to barrier 
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defects and fragile skin (Kumar et al. 2016), whereas K type II-/- die at embryonic 
day 9.5 due to growth retardation (Vijayaraj et al. 2009, Bar et al. 2014). However, 
the deletion of K7 demonstrates only a mild phenotype (Sandilands et al. 2013), 
with hyperprolifereation of the bladder urothelium. Similarily, the K19-/- mouse 
displays a mild phenotype with a mild myopathy (Stone et al. 2007) and a 
cholestatic liver injury (Chen et al. 2015). 
Table 3. SEK knock out mouse models. Knock out mouse models of SEKs generated in C57Bl/6 
or FVB/n strain and their described phenotypes. Table created based on (Strnad et al. 2016, 
Omary et al. 2009). 
Keratin modification 
in mouse strain 
Phenotype Reference 
K7-/- in C57Bl/6 Increased proliferation of bladder uroth   (Sandilands et al. 
2013) 
K8-/- in C57Bl/6 Gestational lethality by liver failure (Baribault et al. 1993) 
K8-/- in FVB/n Colorectal hyperplasia in cecum, colon and  
rectum with colitis and mild hepatitis 
(Baribault et al. 1994) 
K18-/- in C57Bl/6 No clear phenotype in young mice, old mice 
develop MDB, susceptibility to Fas- and 
TNFα-induced liver injury 
(Magin et al. 1998) 
K19-/- in FVB/n Mild myopathy, compensatory overexpression 
of K18 and K20 in gallbladder, attenuated 
ductal reaction in liver injury 
(Stone et al. 2007) 
K8-/-/K19-/- in FVB/n Embryonic lethality due to defects in 
plancenta 
(Tamai et al. 2000) 
K18-/-/K19-/- in FVB/n Embryonic lethality due to defects in placental 
trophoblast giant cells 
(Hesse et al. 2000) 
K type I-/- in FVB/n Embryonic lethality due to barrier defects and 
fragile skin 
(Kumar et al. 2016) 
K type II-/- in FVB/n Embryonic lethality due to severe growth 
retardation 
(Vijayaraj et al. 2009, 
Bar et al. 2014) 
1.2.2 Transgenic mouse models 
In order to study how increased levels of SEKs affect the phenotype and for the 
generation of controls for many overexpressor mutations, both human and mouse 
K8 overexpressing mice have been generated (Table 4). Mice overexpressing 
human K8 show a phenotype of pancreatitis (Casanova et al. 1999) and epidermal 
abnormalities (Casanova et al. 2004), but also increased liver injury (Ku, Omary 
2006) and Mallory Denk body (MDB)-formation in response to high-fat diet 
(Kucukoglu et al. 2014, Ku, Omary 2006). When murine K8 is overexpressed, mice 
are susceptible to develop increased amounts of MDBs (Nakamichi et al. 2005) and 
a exocrine pancreatic phenotype including spontaneous chronic pancreatitis and 
increased levels of type I keratins K18, K19 and K20 (Toivola et al. 2008). 
Overexpression of human WT K18 protects mice from MDB formation (Harada et 
al. 2007), while WT K19 (Bader, Franke 1990) and K20 (Zhou et al. 2003) 
overexpressing mice show no phenotype. 
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To understand the effects of mutations in human disease and the roles of PTM 
sites, mice overexpressing SEK variants (Table 4) were generated. They have mostly 
been studied in regards of the liver phenotype, explaining the liver-dominant 
phenotypes described here. Overexpression of the most common human mutation 
of K8 in mice, the Glycine (G) 62C mutation, does not show any basal phenotype, 
but exhibits a stress-induced liver injury in response to a secondary stress (Ku, 
Omary 2006, Guldiken et al. 2015b). Many mutations of SEK phosphorylation and 
glycosylation in overexpressing mouse lines are used for studying PTMs. For 
example, the human K8 S74A (Ku, Omary 2006) and the human K8 R341C/H 
(Guldiken et al. 2015b) variants predispose mice to liver injury. When all known 
K18 glycosylation sites are mutated (K18 S30/31/49A), mice do not show any basal 
phenotype, only susceptibility to liver and pancreatic injury (Ku et al. 2010). 
Table 4. Selection of transgenic mice overexpressing SEK variants. Mice overexpressing SEK 
variants and their described phenotype. Table created based on (Strnad et al. 2016, Omary et al. 
2009). 
Keratin 
modification 
Phenotype Reference 
K8 human WT 
overexpression 
Pancreatitis and epidermal and hair follicle  
dysplasia 
(Casanova et al. 1999, 
Casanova et al. 2004) 
K8 human WT 
overexpression 
Increased liver injury and MDB formation  
after feeding with high fat diet 
(Ku, Omary 2006, 
Kucukoglu et al. 2014) 
K8 mouse WT 
overexpression 
MDB formation during aging (Nakamichi et al. 2005, 
Toivola et al. 2008) 
K18 human WT 
overexpression 
Protected from MDB formation 
 
(Harada et al. 2007) 
K19 human WT 
overexpression 
None (Bader, Franke 1990) 
K20 human WT 
overexpression 
None (Zhou et al. 2003) 
K8 human G62C Predisposition to selected liver stress 
situations (Fas, microcystin LR, 
acetaminophen) and inhibits phosphorylation 
at S74, reduced ability to form MDBs 
(Guldiken et al. 2015b, 
Ku, Omary 2006) 
K8 human S74A Predisposition to liver injury, reduced ability 
to form MDBs 
(Ku, Omary 2006) 
K8 human R341C/H Predisposition to hepatotoxicity (Guldiken et al. 2015b) 
 
K18 human S30/31/49A
overexpression 
Susceptible to induced apoptosis, liver and 
pancreas injury 
(Ku et al. 2010) 
K type II  Embryonic lethality due to severe growth 
retardation 
(Vijayaraj et al. 2009) 
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1.3 Intermediate filaments and simple epithelial keratins in stress protection 
Except for roles in mechanical stability, the involvement of IF proteins in the 
cellular stress response has recently emerged, which has been reviewed in (Toivola 
et al. 2010). For example, in response to shear stress, vimentin is overexpressed in 
endothelial cells (Tsuruta, Jones 2003) and lamin A in nuclei (Philip, Dahl 2008), 
while skin keratins K6, K16 and K17 are overexpressed in response to wound 
healing and UV-stress (Freedberg et al. 2001, DePianto, Coulombe 2004). 
Regarding SEKs, their dynamic nature is reflected by the fast assembly and 
disassembly of the filamentous network during cell growth and differentiation, but 
also in response to stress. Together with HSPs, the keratin protein family was 
identified as the most differentially expressed protein family when proteomics data 
was collected and meta-analyzed from 188 earlier published articles (Petrak et al. 
2008). K8 was found on place 10, displaying the first piece of evidence for the role 
of SEKs in stress protection. In a similar way as HSPs, SEKs are upregulated both 
on mRNA and protein levels upon stress and recovery (Fig. 2). In the liver, stress-
induced overexpression of hepatic keratins has been shown in human liver disease, 
in murine stress models and in in vitro stress-studies (Guldiken et al. 2015a, 
Zatloukal et al. 2007, Guldiken et al. 2016). Also in other organs of the digestive 
track, as in pancreas, caerulein- and choline/methionine-deficient diet-induced 
murine pancreatitis causes an overexpression of pancreatic SEKs (Zhong et al. 
2004, Wogenstein et al. 2014). Similar organ-specific overexpression of SEKs has 
been reported in kidneys during murine fibrosis, toxin- and injury-related models, 
as well as in human kidney disease (Djudjaj et al. 2016). Similarly, in vitro alveolar 
epithelial keratins are upregulated in response to shear stress (Sivaramakrishnan et 
al. 2009).  
SEK phosphorylation has previously been described during stress, mitosis and 
apoptosis. In response to stress, K8 (Toivola et al. 2002, Djudjaj et al. 2016, Ridge et 
al. 2005, Fausther, Villeneuve & Cadrin 2004, Burcham, Raso & Henry 2014, Liao, 
Ku & Omary 1997, Toivola et al. 2004b), K18 (Sivaramakrishnan et al. 2009, 
Djudjaj et al. 2016, Guldiken et al. 2015a, Toivola et al. 2004b) and K20 (Zhou et al. 
2006) are known to be phosphorylated. K8/K18 phosphorylation in response to 
liver and kidney stress are used as markers of disease (Toivola et al. 2004b, Djudjaj 
et al. 2016). Shown by K8 phosphomutant mice, hyperphosphorylated K8 acts as a 
phosphate buffer/sponge, where stress-activated protein kinase-mediated apoptosis 
is prevented(Ku, Omary 2006). Therefore K8 and especially overexpression of K8 
in stress protects the tissue from injury by serving as a phosphate sponge. 
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Figure 2. SEKs in stress protection. Human and mouse SEKs show significant upregulations and 
increased phosphorylations in response to different stress models.  = upregulation,  = 
downregulation,  = no change, ND = not determined. 
1.4 Gene mutations of simple epithelial keratins 
Mutations in K5 and K14 in the keratinocytes of the skin are known to cause 
epidemolysis bullosa simplex (EBS), a skin blistering disease (Lane, McLean 2004). 
In contrary to this clear connection of disease and keratin mutations in stratified 
squamous epithelium, the role of keratin mutations in simple epithelial disease is 
still not clear, even if some evidence for hepatic, intestinal and pancreatic disease 
exist. About 5% of the human population has mutations in KRT8 and KRT18 
genes, including mostly patients with liver disorders (Toivola et al. 2015). 
In hepatocytes, it has been shown that mutations in KRT8 and KRT18 genes 
predispose to human liver diseases (Ku et al. 2003, Ku et al. 2007, Omary et al. 
2009), meaning that a second hit, e.g. toxins or alcohol, is needed for the outbreak 
of the disease. K8 variants found in humans with liver disease are G62C, Tyrosine 
(Y) 54 Histidine (H), R341H and G434S. The mutations predisposing to liver 
diseases, K8 G62C and K8 G434S, are known to inhibit phosphorylation of nearby 
K8 at S74 and S432, respectively, shown by mouse models that overexpress these 
human mutants (Ku, Omary 2006, Omary et al. 2009).   
Assessment of the role of K8 mutant variants in inflammatory bowel disease (IBD) 
pathogenesis failed to show any major correlation in two major studies (Buning et 
al. 2004, Tao et al. 2007), even if heterozygous missense mutations on KRT8 gene 
have been identified in a few patients (Owens et al. 2004, Owens, Lane 2004). The 
KRT8 and KRT18 gene has been localized to the IBD2 locus on chromosome 12 (de 
Jong, Drenth 2004, Waseem et al. 1990), suggesting a link between IBD and 
K8/K18 mutations. So far, K8 mutations are only considered as predisposing 
factors for IBD. Similarly as in the intestine, SEK variants have not been associated 
with pancreatic disease in neither human patients (Treiber et al. 2006, Schneider et 
al. 2006) nor mouse models (Toivola et al. 2008). Disease associations for 
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mutations in the minor SEKs K7, K19, K20 and K23 have not been identified in 
detail so far. 
1.5 Associated diseases of simple epithelial keratins 
Animal models have contributed to this knowledge by providing insights about 
SEK function by knock out, knock in and overexpressor models. Keratins are 
reorganized in disease, for example by upregulation, aggregation or by 
postranslational modifications (Toivola et al. 2015, Omary et al. 2009, Omary 2009, 
Haines, Lane 2012).  
In liver disease, such as alcoholic liver disease (ALD), nonalcoholic steatohepatitis 
(NASH) and hepatitis C infection (HCV) increased K8 expression partly due to the 
formation of Mallory Denk bodies (MDBs) is seen (Zatloukal et al. 2007). MDBs 
are protein aggregates that constitute of K8, K18, ubiquitin and ubiquitin-binding 
protein p62, and they serve as a marker of liver stress. MDBs are characterized by 
an unbalanced K8/K18 ratio, where excess K8 is predominant (Zatloukal et al. 
2007). 
Some evidence of SEK associated diseases in the intestine has been reported. In 
multifactorial diseases, such as in intestinal diseases, SEKs are proposed to play a 
role in the overall intestinal health. The first evidence of SEK involvement in IBD 
comes from the K8-/- mouse model (Baribault et al. 1994), which suffers from an 
early colitis-like phenotype, which is amendable to antibiotic treatment (Habtezion 
et al. 2005). Colonic keratin levels are altered in human colitis (Corfe et al. 2015), 
providing further evidence on the role of colonic keratins in disease development 
and progression. The K8-/- mouse does not develop colorectal adenocarcinomas 
spontaneously, but when predisposed to a chemical or a genetic tumor model, 
colorectal adenocarcinomas were formed in the colon due to an increase in the 
inflammasome activity. This provides further evidence on the modulating role of 
keratins on colonic inflammation and tumorigenesis (Misiorek et al. 2016).  
Pancreatic SEKs have been shown to increase in caerulein-induced and 
choline/methionine-deficient diet-induced pancreatitis of the exocrine pancreas 
(Zhong et al. 2004, Toivola et al. 2000). Regarding endocrine pancreas, K8 deletion 
causes an increase in glucose tolerance together with insulin sensitivity in diabetes-
induced stress (Alam et al. 2013). The newly emerging role of keratins in the 
kidney has been demonstrated by a study showing keratin upregulation in human 
kidney injury due to myeloma cast nephropathy, diabetic nephropathy and 
systemic lupus erythematosus, as well as in mouse models for kidney 
tubulointerstitial fibrosis, adenine nephropathy, ischemia-reperfusion injury, folic 
acid nephropathy and glomerulonephritis (Djudjaj et al. 2016). Therefore, renal 
SEKs should be considered as potential markers of tubular cell stress in diseased 
murine and human kidneys. It is still unclear if keratin mutations are found in 
patients with kidney disease (Snider 2016). In other organs with simple epithelial 
linings, such as the thymus (Odaka et al. 2013), lung (Sivaramakrishnan et al. 2009) 
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and gallbladder (Kasprzak et al. 2011, Tao et al. 2003), SEKs are likely required 
mainly in the mechanical stress protection, but no clear connections between SEKs, 
diseases and mutations have been established or studied.  
SEKs are also used as markers of disease. Keratins can be used as markers of 
tumors with epithelial origin, while the origin of the primary tumor can be 
distinguished by determining the exact keratin expression pattern of the metastasis 
(Omary et al. 2009). For example hepatocellular carcinomas express K8, K18 and 
K19 (Kim et al. 2011, Govaere et al. 2014), while cholangiocarcinomas express K7, 
K8 and K18 and colorectal carcinomas only K20 (Omary et al. 2009, Chu, Weiss 
2002, Tot 2002).  
The treatment of SEK related diseases are still limited and mostly palliative, 
meaning that the symptoms of the disease are treated rather than the actual cause. 
Gene therapy is considered as another future possible treatment of SEK-related 
diseases, even if this direction is still uncharted (Omary 2009, Haines, Lane 2012).   
2. Colon 
The digestive tract, which extends from the mouth to the anus, consists of the oral 
cavity, esophagus, stomach, pancreas, liver, small intestine and colon. In humans, 
the colon is approximately 1.5m long, and it is divided from the proximal to distal 
end into the ascending colon, transverse colon, descending colon, sigmoid colon 
and rectum. The inner part of the colon, i.e. the lumen, is lined with a single-layer 
of epithelial cells that form invaginations, called colonic crypts (Fig. 3). The lamina 
propria is situated underneath the epithelial crypts, where immune cells, blood 
vessels, lymphatics and nerves are found. Beneath the lamina propria is a thin 
muscular layer that contributes to the local peristaltic movements of the colon. In 
the submucosa, blood vessels and collagen fibers can be found, whereas the next 
muscular layer consists of smooth muscles responsible for the continued peristaltic 
movements. The outermost layer of the colon is the serosa, which consists of 
connective tissue, protecting the colon from outer damage in the abdominal cavity 
(Ross 2015). 
The main function of the intestinal epithelium is to absorb excess water and salts 
from food digested in the small intestine. Another important function is to absorb 
vitamin K, vitamin B12, riboflavin and thiamin as fermentation products from 
intestinal bacteria. The colonic epithelium forms the foremost protection against 
outer stresses, such as microbes and toxins ingested with the food (Ross 2015). 
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Fig. 3. Colon layers, cell types and regulatory signaling pathways. Serosa, muscular layers, 
mucosal layers, lamina propria and epithelial layers make up the colonic structure. The single-
layered epithelium consists of colonic crypts, where proliferating epithelial progenitor cells are 
regulated by Wnt signaling based at the bottom of the crypts and Notch-signaling which regulates 
the differentiation of the cells at the top of the crypts. Hippo and BMP signaling inhibits 
proliferation and induces maturation of all secretory cell types. Figure based on (Jeon et al. 2013). 
2.1 Colon epithelial cells 
The colonic crypts consist of a single layer of epithelial cells. Undifferentiated 
colonic stem cells are found at the bottom of the crypts, from where they 
proliferate further upwards in the crypt and differentiate into different kinds of 
colonic cells (Fig. 3). Eventually, these cells die of apoptosis at the top of the crypt 
after 3-5 days (Clevers 2013, Ratanasirintrawoot, Israsena 2016).  
At the bottom of the crypts, crypt base columnar (CBC) cells and +4 cells have 
been identified as intestinal stem cells, which express Lgr5, widely used as an 
intestinal stem cell marker (Cheng, Leblond 1974, Ratanasirintrawoot, Israsena 
2016, Clevers 2013). These intestinal stem cells have been shown to be able to 
differentiate to all intestinal cell types both in vivo (Barker et al. 2007) and in vitro 
(Sato et al. 2009). As the colonic stem cells move towards the intestinal lumen, they 
lose their progenitor cell identity and become transit-amplifying (TA) cells. TA 
cells can differentiate into two cell lineages, absorptive cells (enterocytes) and 
secretory cells (goblet cells, tuft cells and enteroendocrine cells) (Clevers 2013).   
Cell types present at the whole differentiating crypt-axis are enterocytes, 
enteroendocrine cells, goblet cells and tuft cells. The main intestinal cells are the 
absorptive enterocytes, whose main function is absorption of water and nutrients. 
Enterocytes are polarized cells with a luminal brush border. Enteroendocrine cells 
are specialized cells that secrete their own cell-specific hormone (Gunawardene, 
Corfe & Staton 2011), as for example somatostatin that inhibits other 
gastrointestinal hormones. The role of enteroendocrine cells in colorectal cancer 
(CRC) is still unclear, but it has been suggested that enteroendocrine cell 
perturbation may have a role in the pathology of CRC (Hamada et al. 1992) or even 
the other way around, that colorectal tumors themselves cause perturbations in the 
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balance of enteroendocrine cells (Nitta et al. 2001). Mucus-secreting goblet cells are 
distributed all over the crypt length. Recent studies have shown interactions 
between colonic microbiota and goblet cells by showing that an IBD-like 
phenotype contributes to intact mucus layers in mice (Johansson, Hansson 2013).  
Different junction proteins mediate the cell-cell contact between the epithelial cells 
of the colonic epithelium. Desmosomal proteins from the cadherin-family tie the 
epithelial cells together by connecting the cytoskeletal SEK networks of two cells 
together, forming an intact epithelium in between cells (Nekrasova, Green 2013). 
Gap junction proteins, proteins from the connexin-family, form pores between 
cells, allowing cytosolic matter to be transported from one cell to another (Bennett 
et al. 1991). The most important proteins in regards of the intestinal barrier are the 
tight junction proteins from claudin and occuldin protein-families, which form 
junctions around the top of the intestinal epithelium (Groschwitz, Hogan 2009). 
Other junction proteins found in the intestine are catenin in adherens junctions at 
the membranes between cells and hemidesmosomes that attach the epithelial cells 
to the basal lamina (Groschwitz, Hogan 2009). 
2.1.1 Colonocyte proliferation and differentiation 
The colonic epithelium is constantly in a renewal state, and the whole epithelial 
layer is renewed in 3-5 days. The homeostasis of the intestinal epithelium is 
maintained by a number of signaling pathways. The Hedgehog, TFG-β and BMP 
pathways maintain the crypt structure, while the Wnt, Notch, and Hippo signaling 
pathways together control the cell proliferation and differentiation from intestinal 
stem cells (Fig. 3) (Jeon et al. 2013).  
The proliferation of colonic epithelial stem cells is highly regulated by the Wnt-
signaling pathway and its key regulator β-catenin (Clevers, Nusse 2012, Pinto et al. 
2003, Haegebarth, Clevers 2009). The repressing of this pathway by the tumor 
suppressor Adenomatous polypsis coli (APC), which is a negative regulator of the 
Wnt-signaling pathway, drives the colon epithelia towards CRC (Krausova, 
Korinek 2014, Jeon et al. 2013). As the Wnt-signalling pathway controls the 
proliferation of the intestinal epithelium, the differentiation of CBC stem cells to 
differentiated cells is regulated by the Notch-signaling pathway (Clevers 2013, 
Sancho, Cremona & Behrens 2015) . Active Notch signaling leads to high 
differentiation levels of progenitor cells to absorptive enterocytes, while the 
inhibition of Notch signaling shifts the progenitor cell differentiation towards 
secretory cells such as goblet cells, enteroendocrine cells and tuft cells (Sancho, 
Cremona & Behrens 2015).  
In contrast to the Wnt- and Notch signaling pathway, the Hippo signaling pathway 
regulates intestinal regeneration and tumorigenesis. This tumor-suppressing 
pathway inhibits proliferation and the deletion of the downstream protein Yes-
associated protein (YAP), results in undifferentiated stem cells and in the absence 
of all secretory cell types (Cai et al. 2010, Karpowicz, Perez & Perrimon 2010). 
Another proliferation inhibitory pathway is the BMP pathway, which antagonizes 
Review of the Literature 
16 
the Wnt-pathway and induces maturation of the secretory cell types  (Jeon et al. 
2013, Radtke, Clevers & Riccio 2006). A signaling pathway that regulates intestinal 
repair is the hedgehog-signaling pathway. Hedgehog signaling decreases during the 
injury phase and increases during the repair phase. This pathway activates 
transcription factors from the glioblastoma (GLI)-family, which in turn activate 
transcription of target genes. The three known hedgehog-proteins regulating the 
hedgehog-pathway in the intestine are sonic hedgehog (Shh), indian hedgehog 
(Ihh), and desert hedgehog (Dhh) (van den Brink 2007, Liang et al. 2012) . The 
transforming growth factor β (TGF-β) signaling pathway regulates embryonic 
development, repair, proliferation, and cell differentiation of the intestine (Shi, 
Massague 2003). 
2.2 Colonic microbiota 
The microbiota of the gastrointestinal tract consists except for archea, viruses and 
fungi, mostly of bacteria, which include non-pathogenic commensal bacteria 
(bacteria that do not cause disease) and pathogenic bacteria (bacteria that cause 
disease) that inhabit the intestine in symbiosis. The intestinal bacteria can shift 
from non-pathogenic to pathogenic state in response to stress situations, such as in 
disease (Chow, Tang & Mazmanian 2011, Sekirov et al. 2010). Perturbations in the 
intestinal microbiota have been implied to be a major cause in the development of 
IBD, which has been verified partly by the fact that the areas of active IBD are areas 
with high numbers of bacteria (Quigley 2013), and partly by studies showing a 
positive outcome for IBD patients by modifying their microbiota by probiotics 
(Rachmilewitz et al. 2004, Isolauri, Salminen 2005). Furthermore, Faecalibacterium 
prausnitzii, which is a bacterium with anti-inflammatory properties, has been 
found to be less abundant in patients with IBD compared to healthy controls 
(Sokol et al. 2009). Also, many recent studies have shown successful outcomes in 
treating Clostridium difficile diarrhea with faecal microbiota transplants (FMT) 
(Leszczyszyn, Radomski & Leszczyszyn 2016).  
The role of microbiota in the development of obesity (Ridaura et al. 2013, 
Turnbaugh et al. 2006, Ley 2010), cancer (Wu et al. 2009) and autoimmune 
diseases (Kim, Yoo & Kim 2016)  such as diabetes, rheumatois arthritis and 
multiple sclerosis has been reported. The presumed protective role of the 
commensal microbiota comes from inhibiting proliferation of pathogenic bacteria, 
competing for nutrients and occupying the mucosa of pathogens (Nagao-Kitamoto 
et al. 2016). The intestinal microbiota has also been proposed to play an important 
role in the energy homeostasis of the colonic epithelium by maintaining the cell 
barrier and anti-inflammatory immunity with the help of short chain fatty acids 
(SCFA). SCFA are produced by intestinal microbiota, which fermentate dietary 
fiber into SCFA (Furusawa et al. 2013, Lewis, Heaton 1997, Quigley 2013). Another 
important function of colonic microbiota is the synthesis of vitamins B and K 
(Quigley 2013). 
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The intestinal microbiota consists of 300-500 different bacterial species and 2 
million different bacterial genes (Quigley 2013). In the adult intestine, the most 
prominent phyla are Firmicutes and Bacteroidetes (Fig. 4), which are developed by 
the age of three years (Qin et al. 2010, Sekirov et al. 2010). The composition of the 
adult microbiome is thought to be individual, even though the genera Enterococcus, 
Clostridium, Bifidobacterium and Bacteroides are found dominant in all adult 
intestines regardless of ethnicity, culture or sex (Arumugam et al. 2011). Before the 
age of three years, Proteobacteria and Actinobacteria dominate the intestine of the 
infant (Koenig et al. 2011), and the colonization of the newborns sterile intestine by 
these species is influenced by different factors such as mode of delivery, sanitation 
and exposure to antibiotics (Marques et al. 2010). During the aging of the intestine, 
the same phyla Firmicutes and Bacteroidetes are found dominant, even if the ratio 
between these radically shifts towards Bacteroidetes (Mariat et al. 2009). 
 
Figure 4. The bacterial genera present in the adult gastrointestinal tract. A. The amount of 
bacteria (bacteria/gram) in the digestive tract increases towards the colon, where the phyla 
Firmicutes and Bacteriodetes are prominent. B. Longitudinal variations in bacteria and bacterial 
phyla found in the colon. Figure based on (Sekirov et al. 2010, Pei et al. 2004). 
2.3 Colon in stress and recovery 
The colon is exposed to various stresses through the colonic lumen and the intact 
single-layered epithelium that lines the inner part of the colon acts as the first line 
of response against outer stress. The fast renewal of the colonic epithelium enables 
regeneration in response to stress and injury. The most common stress models 
related to human diseases and the treatment of human diseases are described 
below.  
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2.3.1 Inflammational stress and model systems 
The intestinal inflammational stress response is characterized by the loss of 
intestinal barrier function and increased epithelial permeability, mediated by 
cytokines and immune cells (Groschwitz, Hogan 2009). The most common 
mediators of intestinal inflammation in IBD are pro-inflammatory cytokines such 
as tumor necrosis factor-α (TNFα) (Ye, Ma & Ma 2006, MacDonald et al. 1990), 
interferon-γ (IFNγ) (MacDonald et al. 1990) and interleukin-22 (IL-22), together 
with the pro- and anti-inflammatory cytokines TGFβ and interleukin-10 (IL-10) 
(Madsen et al. 1999). They are produced by different T cell differentiation patterns, 
so that cytokines secreted in Crohn’s disease (CD) are derived by TH1 and TH17 T 
cell differentiation while ulcerative colitis (UC) cytokines are derived from TH2 T 
cell differentiation (Strober, Fuss 2011). Anti-inflammatory cytokines are involved 
in maintaining intestinal homeostasis, shown for example by the IL-10 KO mouse 
which develops colitis, while pro-inflammatory cytokines are known to be 
increased in diseased intestinal tissues such as in IBD and CRC (Sanjabi et al. 
2009). 
The most commonly used model for colonic inflammation is the chemically 
induced dextran sulphate sodium (DSS)-colitis, administered in drinking water. 
DSS-treatment causes weight loss, occult blood in stool, piloerection and anemia. 
Histologically, mucin depletion, neutrophil infiltration, cryptitis, crypt abscess and 
inflammation in mucosa and submucosa can be seen. DSS is directly toxic to gut 
epithelial cells by affecting the integrity of the mucosal and epithelial barrier. This 
loss of barrier function enables entry of luminal microbiota and their products to 
the underlying lamina propria, which stimulates the innate immune system and 
causes an immune response. DSS-colitis is duration-, concentration-, molecular 
size- and strain-dependent, meaning that the severity of the experimental colitis 
varies with different experimental setups (Perse, Cerar 2012). For example, acute 
DSS colitis is achieved by a 2% DSS-treatment for one week, while chronic colitis 
requires a cyclic treatment with recovery periods in between (Breynaert et al. 2013). 
The molecular size of the used DSS also determines the outcome of the treatment. 
54 kDa DSS is carcinogenic due to the induction of colitis-induced dysplastic 
regions, while larger or smaller molecular sizes of DSS do not induce carcinogenic 
activity in the colon. The molecular size of DSS also affects the location of the 
colitis; for example 40 kDa DSS induces colitis in distal colon (DC) while 5 kDa 
DSS induces colitis in proximal colon (PC) and cecum (Perse, Cerar 2012, Rose, 
Sakamoto & Leifer 2012).  
Another murine inflammational model that causes colonic hyperplasia, diarrhea 
and colonic inflammation is the Citrobacter rodentium-induced colitis model. 
Citrobacter rodentium is a gram-negative bacterium that is administered by oral 
gavage, after which it colonizes the gastrointestinal system and acts as a rodent 
equivalent to the human bacterial infection Eschericia Coli (E. Coli). The 
mechanism of action is not fully understood, but indications of the involvement of 
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the bacteria in attaching and effecting intestinal lesions have been shown (Mundy 
et al. 2005, Collins et al. 2014). 
A model used for both in vivo and in vitro inflammation is LPS treatment. LPS is a 
major component in the cell membrane of gram-negative bacteria. LPS activates 
different signaling events, for example the activation of nuclear factor κB (NF-κB) 
(Medzhitov, Preston-Hurlburt & Janeway 1997), which in turn lead to the release 
of a number of proinflammatory cytokines, such as different interleukins and TNF-
α (Chow et al. 1999, Cario et al. 2000). By treating intestinal cell lines, such as 
Caco-2 and HT29 cells, with LPS, an activation of colonic in vitro stress-mediated 
inflammatory pathways can be achieved (Cario et al. 2000). In vivo activation of 
stress-mediated inflammatory pathways can be achieved by intra peritoneal (i.p.) 
injection of LPS on mice.  
Genetic mouse models displaying an inflammatory phenotype (Mizoguchi et al. 
2016) are for example the K8-/- (Baribault et al. 1994) and Il-10-/- (Kuhn et al. 1993) 
mouse models. The K8-/- mouse model displays a spontaneous TH2-type colitis, 
resembling the IBD phenotype. The Il-10-/- colitis is ameliorated by germ-free 
conditions (Matharu et al. 2009), and both the K8-/- (Habtezion et al. 2005) colitis 
and the Il-10-/- colitis (Madsen et al. 2000) are amendable to a broad-spectrum 
antibiotic treatment. 
2.3.2 Removal of microbiota 
The most commonly known model for removal of microbiota is the antibiotic 
treatment-induced diarrhea, where broad-spectrum antibiotics not only depletes 
the pathogens, but also depletes most of the normal flora so that other pathogenic 
organisms can colonize the colon after the antibiotic treatment (Sekirov et al. 
2010). Severe diseases caused by antibiotic treatment are for example colitis caused 
by Clostridium difficile and necrotizing enterocolitis in infants (Quigley 2013). 
Except for eliminating the normal microflora, an antibiotic treatment may cause a 
mild gut inflammation, an enlarged cecum, fewer Peyer’s patches and an increased 
expression of several toll-like receptors (TLRs) (Cerf-Bensussan, Gaboriau-
Routhiau 2010, Grasa et al. 2015). Antibiotic therapy is also known to prevent and 
treat genetic colitis models such as those seen in the K8-/- (Habtezion et al. 2005) 
and Il-10-/- (Madsen et al. 2000) mice.  
2.4 Colon epithelial cell energy homeostasis 
2.4.1 Short chain fatty acids in colonic energy homeostasis 
Under basal conditions, the main energy source for colonic epithelial cells is SCFA, 
derived from the fermentation of dietary fiber by the colonic microbiota. The most 
commonly found SCFAs in the colon are the unbranched SCFAs acetate, 
propionate and butyrate, which account for 90% of all present SCFAs in the colon. 
Other branched SCFAs found in the colon are isobutyrate, valerate, isovalerate and 
hexanoate. SCFAs are primarily formed in in the proximal colon where access to 
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dietary fibers and colonic microbiota is higher. Also, the environment is more 
favorable for SCFA formation in the proximal colon compared to the DC where 
toxic metabolites such as ammonia and sulphur-containing compounds are formed 
in a larger extent (Hamer et al. 2008). The SCFAs acetic acid, propionic acid and 
butyric acid are mostly found in acid form in the acidic stomach, while they form 
salts (sodium acetate, sodium propionate and sodium butyrate) in the alkaline 
environment of the colon. Except for free diffusion of lipid-soluble protonated 
SCFAs across the cell membrane, water-soluble ionized SCFAs are transported into 
colonocytes by two different active transporters: MCT1(Cuff et al. 2005) and solute 
carrier family 5 member 8 (SLC5A8) also called sodium-coupled monocarboxylate 
transporter 1 (SMCT) (Gupta et al. 2006). MCT1 is a proton (H+)-coupled active 
transmembrane transporter, whereas SLC5A8 is a sodium (Na+)-coupled active 
transmembrane transporter. The most potent SCFA is butyrate, and it is mostly 
transported into the colonocytes via active transport.  
Butyrate acts as an inhibitor of the protein histone deacetylase (HDAC), which in 
contrary to the protein histone acetyltranferase (HAT) removes acetyl-groups from 
histones. Therefore the HDAC inhibitor, i.e. butyrate, hyperacetylates histones, 
which in turn binds transcription factors more easily and facilitates transcription 
(Lazarova, Bordonaro 2016). Besides for butyrate’s role as an energy source for the 
colonocytes, it has lately emerged as a protector of both CRC and IBD. The 
butyrate-mediated tumor-suppression is thought to rely partly on the fact that 
cancerous colonocytes produce energy by fermentation of lactic acid via glycolysis 
in the cytosol (Fig. 5B) as its primary energy source (Warburg effect) instead of 
oxidizing SCFAs in the mitochondria (Fig. 5A) (Donohoe et al. 2012). Although 
Warburg effect is seen in normal stem cell metabolism (Kaiko et al. 2016), it is 
more prominent during CRC in the whole crypt-axis. Due to the active glycolysis 
of the cancerous colonocyte, butyrate is accumulated inside the nucleus where it 
functions as an HDAC inhibitor, which regulates genes involved in colonocyte 
proliferation, diffentiation and apoptosis (Bultman 2016). The cancer-protective 
role of butyrate has also been shown by the ability of butyrate to inhibit excess stem 
cell proliferation (Kaiko et al. 2016). The protective mechanism in IBD also relies 
on the fact that butyrate acts as an HDAC inhibitor, leading to increased apoptosis 
and reduction of pro-inflammatory cytokines (Felice et al. 2015).  
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Figure 5. Energy metabolism of normal and diseased colon. A. During normal conditions, 
butyrate produced by colonic microbiota is transported into the colonocyte by SLC5A8 or MCT1, 
where after it is primarily β-oxidized to acetyl CoA in the mitochondria. Acetyl CoA enters 
ketogenesis, which produces the three ketone bodies acetoacetate, acetone and β-hydroxybutyrate, 
controlled by HMGCS2. B. In disease, such as CRC or IBD, the colonocyte uses glucose for energy 
due to the Warburg effect where cytosolic glucose is fermentated to lactic acid via glycolysis 
(dotted arrows indicate hidden steps). Butyrate is accumulated in the nucleus and acts as an 
inhibitor of histone deacetylation, leading to decreased proliferation and increased apoptosis via 
histone hyperacetylation that promotes transcription of controlled genes. Figure based on 
(Bultman 2016). 
2.4.2 Colonic ketogenesis  
Ketogenesis is the process where fatty acids are broken down to ketone bodies and 
energy. Fatty acids are β-oxidized to acetyl CoA in the mitochondria, from where 
acetyl CoA normally enters the citric acid cycle and further to the electron 
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transport chain to produce energy in the form of ATP. Alternatively, due to over 
production of acetyl CoA or in response to low carbohydrate-levels, acetyl CoA can 
enter the ketogenic pathway, which produces the three ketone bodies acetoacetate, 
acetone and β-hydroxybutyrate. If too much ketone bodies are produced, as for 
example during fasting, high-fat diet or during untreated diabetes, ketoacidosis 
occurs in response to insufficient levels of carbohydrates. In this state fatty acids 
alone are used for energy, resulting in an accumulation of H+-binding ketone 
bodies that is a life-threatening situation. Ketogenesis occurs mainly in liver and 
colon, but in smaller extents also in skeletal muscles, heart, kidneys, testes and 
pancreas (VanItallie, Nufert 2003, Hegardt 1999). 
2.4.3 Regulation of ketogenesis 
The main rate-limiting enzyme of ketogenesis is 3-hydroxy-3-methylglutaryl-CoA 
synthase (HMGCS2), which catalyses the condensation of acetoacetyl CoA and 
acetyl CoA to form 3-hydroxy-3-methylglutaryl CoA (HMG CoA) and free CoA 
(Fig. 5A). HMG CoA is active at two sites and produced by two different proteins 
encoded by two different genes: in the cytosol HMG CoA is produced by the 
cytosolic 3-hydroxy-3-methylglutaryl-CoA synthase (HMGCS1) and in the 
mitochondria HMG CoA is produced by the mitochondrial 3-hydroxy-3-
methylglutaryl-CoA synthase (HMGCS2). The cytosolic enzyme produces several 
important factors related to the isoprenoid biosynthesis pathway, such as 
cholesterol. The mitochondrial enzyme acts as the most important control site of 
the ketogenic pathway (Hegardt 1999, Fukao, Lopaschuk & Mitchell 2004).  
The transcriptional regulation of HMGCS2 is mainly controlled by the 
transcription factor peroxisome proliferator-activated receptor α (PPARα), which 
activation is regulated by the amount of fatty acids present (Rodriguez et al. 1994). 
Other transcription factors that are known to regulate HMGCS2 transcription are 
cis-retinoid receptor (RXR), specificity protein 1 (Sp1) and cAMP regulatory 
element binding protein (CREB). Fatty acids activate the heterodimerizing of 
PPARα to RXR, which activates the binding to a specific DNA sequence called 
peroxisome proliferator regulatory element (PPRE) that initiates the transcription 
of the gene coding for HMGCS2 (Meertens et al. 1998, Hegardt 1998, Hegardt 
1999). Another mechanism of HMGCS2 regulation is HMGCS2 succinylation and 
acetylation. These posttranslational modifications both reduce the activity of 
HMGCS2, whereas the desuccinylation and deacetylation increases HMGCS2 
activation (Quant, Tubbs & Brand 1990, Newman, Verdin 2014).   
2.4.4 Starvation and ketogenic diet 
Both starvation and ketogenic diets causes a switch in the energy metabolism from 
normal carbohydrate-enforced citric acid cycle to the fatty acid-enforced 
ketogenesis that produces ketone bodies used for energy (Newman, Verdin 2014, 
Cullingford, Eagles & Sato 2002) . The ketogenic diet is a diet that contains high 
levels of fat and low levels of carbohydrates and protein (in a 4:1:1 ratio), 
stimulating the ketogenic pathway to produce ketone bodies for energy. Earlier 
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studies have clearly shown, that the ketogenic diet significantly increases blood 
ketone bodies, liver HMGCS2 levels (Cullingford, Eagles & Sato 2002)  and 
protects against pentylenetetrazole-induced epileptic seizures (Bough, Eagles 
1999). The ketogenic diet is known to significantly increase lifespan by increasing 
resistance to neurological diseases such as epilepsy and Alzheimer’s, Parkinson’s 
and Huntington’s disease. The mechanism of action for this is still unclear, but the 
neuronal changes in ATP production, altered neuronal pH, inhibitory effects of 
ketone bodies on ion channels or synthesis of the inhibitory neurotransmitter 
gamma aminobutyric acid (GABA) have been proposed (Freeman et al. 2006, 
Cullingford, Eagles & Sato 2002).  
2.5 Diseases of the colon 
2.5.1 Inflammatory bowel diseases  
IBD is for now an incurable disease, where the active disease phase is followed by 
remission. IBD comprises the two main intestinal inflammatory diseases, CD and 
UC, and they are both characterized by chronic intestinal epithelial damage. CD 
differs from UD by affecting the whole GI tract rather than only the colon and 
rectum as UC does. At the molecular level, UC is restricted to the epithelial layer of 
the colon, whereas CD can affect all layers of the colon (Baumgart, Carding 2007). 
Although the areas affected are different in CD and UC, the symptoms including 
diarrhea, abdominal pain, rectal bleeding and weight loss are the same for both 
diseases (Baumgart, Carding 2007). Other inflammatory intestinal diseases that are 
not classified as IBD are microscopic colitis (collagenous and lymphocytic colitis) 
and diverticular disease. 
The development of IBD is thought to be due to a combination of genetic risk 
factors, reduced and altered levels of gut microbiota (Nagao-Kitamoto et al. 2016) 
and environmental factors that ultimately lead to an inflammatory response in the 
intestine (Blander 2016, Nagao-Kitamoto et al. 2016, Baumgart, Carding 2007). 
IBD is characterized by an increased amount of apoptosis, where intestinal 
epithelial cells die faster compared to healthy controls (Chen et al. 2010, Nunes, 
Bernardazzi & de Souza 2014, Hagiwara, Tanaka & Kudo 2002, Sartor 2006). 
Except for increased apoptosis, increased permeability of intestinal epithelial cells 
is also observed in IBD, which together with a defective mucosal barrier allows a 
close contact of the luminal content with underlying layers and endothelial cells. 
Microbial factors and epithelial cell abnormalities might facilitate the 
immunological response seen in IBD. IBD is an immune-mediated disease, 
characterized by an abnormal mucosal immune response. In response to the 
initiated immune response, pro-inflammatory and anti-inflammatory cytokines are 
produced, and a perturbation in the balance between these cytokines is thought to 
be a contributing factor to the outbreak of IBD(Neurath 2014). Currently it is not 
known if the increased apoptosis, increased permeability of the intestinal epithelial 
cells or the imbalance in cytokines is a cause or a consequence of the disease 
(Baumgart, Carding 2007, Michielan, D'Inca 2015).  
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To date, there is no known treatment for CD or UC. Immunosuppressive 
medication can be used to control the inflammatory response, and steroids are 
being used for their anti-inflammatory properties. Anti-inflammatory drugs can 
also be combined with drugs that keep the disease in remission. Sometimes 
surgery, like colostomy or ileostomy, is necessary to remove the most inflamed 
areas. TNF antagonists have traditionally been used as medical therapy for IBD 
(Beigel et al. 2014), even if many patients fail to respond to the treatment (Dulai, 
Sandborn 2016). A novel treatment that has recently gained substantial interest is 
FMT, which has shown positive results regarding successful IBD therapy (Pigneur, 
Sokol 2016). 
The epidemiology of IBD shows that the incidence is higher in northern Europe 
and North America (M'Koma 2013). This could partly be explained by the genetic 
risk factors, such as susceptibility alleles (Khor, Gardet & Xavier 2011), but other 
predisposing factors such as diet, sanitation and other environmental factors are 
needed for the development of IBD. The highest prevalence of UC is found in 
Europe, where 505 persons of 100 000 inhabitants are affected, most of whom are 
diagnosed during the first two decades of their life (Ye et al. 2015).  
2.5.2 Colorectal cancer 
CRC originates from abnormal growth of epithelial cells in colon and rectum. 
Genetic mutations in the Wnt signaling pathway are known to cause CRC by 
mutations in the APC gene. APC inhibits β-catenin accumulation, leading to the 
inhibition of oncogene transcription. The tumor suppressor protein, tumor protein 
p53 (p53), regulates pathways associated to cell differentiation and proliferation 
such as the Wnt signaling pathway. Mutations in the p53 gene, as well as in the 
apoptosis activator Transforming growth factor-β (TGF-β), often lead to CRC. 
Also mutations in other proto-oncogenes such as Kirsten rat sarcoma viral 
oncogene homolog (KRAS) and RAF proto-oncogene serine/threonine-protein 
kinase (c-Raf) are crucial in the development of CRC by over-activating cell 
proliferation (Markowitz, Bertagnolli 2009). Except for spontaneously developing 
CRC, chronic inflammation in IBD-patients is a major risk factor for developing 
colitis-associated CRC (Axelrad, Lichtiger & Yajnik 2016, Markowitz, Bertagnolli 
2009).  
If CRC is detected at earlier stages, the prognosis is good due to surgical removal of 
the tumors. During later stages, when liver and lung metastases are usually seen, 
neither surgery, chemotherapy or radiation therapy has been shown to be 
successful (Cunningham et al. 2010). CRC epidemiology is similar to the 
epidemiology of IBD: found mostly in industrialized countries in Europe and 
North America with an annual diagnosis rate on 1 000 000 people. It is among the 
five most commonly found cancers causing death (Cunningham et al. 2010). 
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3. Simple epithelial keratins in colon 
3.1 Simple epithelial keratin expression and regulation in colon 
K7, K8, K18, K19, K20 and K23 are classified as SEKs since they are all expressed in 
single-layered epithelia (Omary et al. 2009). Even if specific keratin-pairs are 
tissue-specifically expressed in different epithelial organs, the intestine is the only 
known organ where all SEKs are expressed basally. Of type II keratins, only K8 is 
expressed in the whole colonic crypt. The presumable type I pair to K8 are K18 or 
K19, both expressed throughout the crypt. Therefore K8, K18 and K19 are the most 
prominently found keratins in the colonic epithelial cells. Type II K7 and type I 
K20 are expressed in lesser extent, and K7 can be found at the bottom of the crypts 
while K20 is found only at the top of the crypts close to the intestinal lumen (Fig. 6) 
(Zhou et al. 2003) . The most recently described SEK, type I K23, is likely expressed 
only in small amounts in the colon (Guldiken et al. 2016).  
The fast renewal rate of the colonic epithelium requires all SEKs to be in a dynamic 
state. Colonic SEKs are present in soluble and insoluble filamentous states. During 
normal conditions, 95% of the filaments are in the insoluble filamentous form. In 
response to stress, keratins reorganize mostly in response to PTMs (Toivola et al. 
2010). The main PTMs are S/T/Y phosphorylation, lysine acetylation, S/T 
glycosylation and sumoylation. Keratin phosphorylation shifts the keratin pool 
against a more soluble pool where keratins appear as granules (Woll, Windoffer & 
Leube 2007, Snider, Omary 2014). The insoluble filamentous keratin pool can be 
solubilized by high concentrations of urea (9M) or guanidine hydrocloride (4-6M) 
(Snider, Omary 2014, Majumdar et al. 2012). The role of in vivo sumoylation in 
maintaining intestinal stem cells and proliferation has been shown, where K8 has 
been identified as a substrate for SUMO(Demarque et al. 2011).  
 
 
Figure 6. SEKs expressed in the 
colon during baseline conditions. 
K8 (type II), K18 (type I) and K19 
(type I) are the main keratins 
expressed in the single-layered 
epithelium of the colon. K7 (type II) 
and K20 (type I) are expressed in a 
lesser extent mainly so that K7 is 
expressed at the bottom of the crypts 
and K20 at the top of the crypts. The 
distribution of the colonic type I K23 
has not been described yet. Bar width 
indicates SEK amount and height 
indicates SEK distribution. Figure 
based on (Zhou et al. 2003). 
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3.2 Simple epithelial keratin functions in colon 
The function of all SEKs present in the colon has not been clarified in detail yet. 
SEK functions in other organs, such as the liver and pancreas, show similarities 
with known intestinal functions of SEK, although some functions are organ-
specific and dependent on other secondary factors, such as the impact of e.g. the 
intestinal microflora. The intestine is, to present knowledge, the only organ where 
all SEKs are present (Majumdar et al. 2012, Pastuszak et al. 2015, Coch, Leube 
2016), thus the compensatory role of the intestinal keratins might be significant in 
the outcome of the different phenotypes. This is seen for example in the K18-/- 
mouse model, which does not display any specific phenotype likely due to the 
compensatory role of type I K19 (Magin et al. 1998).  
The most significant evidence of the role of intestinal K8 comes from the K8-/- 
mouse phenotype. This mouse lacks almost all type II keratins, leading to no 
functional keratin-filaments (Baribault et al. 1994). As the K8-/- mouse develops a 
TH2-type colitis, diarrhea and hyperplasia (Habtezion et al. 2005), a function for 
colonic keratins in the development of IBD has been suggested. Unlike in liver (Ku 
et al. 2016), where the lack of K8 is known to induce apoptosis, lack of colonic K8 
leads to a microbiota-dependent resistance to apoptosis (Habtezion et al. 2011), 
while lack of small intestinal K8 does not show any changes in the rate of apoptosis 
(Ameen, Figueroa & Salas 2001). In the K8-/- mouse, the anion exchanger AE1/2 
and the Na-transporter ENaC-γ are mislocalized (Toivola et al. 2004a) and there is 
a complete loss of the Cl-transporter DRA (Asghar et al. 2016). Disturbances in the 
ezrin-actin scaffold have been reported in intestinal epithelial cells with altered 
levels of K8 (Wald et al. 2005), showing the significance of keratins in protein 
targeting. Type I K18 has been identified to interact with the chloride transporter 
cystic fibrosis transmembrane conductance regulator (CFTR) in small intestine 
and gall bladder (Duan et al. 2012), suggesting a role for K18 and its partner in the 
regulation of CFTR distribution in small intestine. However, CFTR levels were not 
altered in the colon of K8-/- mice (Asghar et al. 2016). K8 has also been proposed a 
role in the regulation of innate immunity. When toll-like receptor (TLR)-signaling 
is activated, K8 inhibits TRAF6-polyubiquitination, which is necessary for the 
transcription of proinflammatory genes such as NF-κB. Shown by both in vivo and 
in vitro models, this further confirms the protective role of K8 in the colonic 
epithelium (Dong et al. 2016).  
In the intestine, desmosomal and tight junction proteins attach colonocytes to each 
other and hemidesmosomal proteins attach the single-layered epithelium to the 
basal membrane, essential for maintaining the intestinal barrier function. Keratins 
are anchored to these structures and have been proposed a role in the formation of 
the IBD phenotype (Baumgart, Carding 2007, Sartor 2006). Surprisingly, when the 
small intestinal desmosomal protein desmoplakin (DP) is missing, keratin filament 
localization was not affected, even if keratin filaments were no longer anchored to 
the desmosomes. However, the microvilli in DP-lacking enterocytes were shorter, 
indicating a role for keratin-bound desmosomes in the organization of the 
Review of the Literature 
27 
intestinal brush border (Sumigray, Lechler 2012). The intestinal permeability of the 
K8-/- colonocytes was increased in one study when compared to K8+/+ colonocytes 
(Misiorek et al. 2016) but unchanged in another (Toivola et al. 2004a). Small 
intestinal K8-/-enterocytes also showed an increased permeability (Mashukova et al. 
2009). In colonocytes, colonic cancer cells expressing K8/K18 mutations (K8 G62C, 
K8 K464N, K18 S230T) displayed increased permeability and diffuse distribution 
of tight junction proteins zonula occludens-1 (ZO-1) and claudin-4, suggesting 
that K8/K18 play a role in colonic barrier function (Zupancic et al. 2014). Similarly, 
when the colonic barrier function was compromised by DSS-treatment, Il-6-/- mice 
showed an increased colonic permeability mediated by K8/K18 (Wang et al. 2007). 
K8 has also been suggested to play a role in the polarization and the organization of 
the small intestinal apical cell membrane, shown by the loss of apical membrane 
proteins in K8-/- mice (Ameen, Figueroa & Salas 2001). Similarly, downregulation 
of K19 showed abnormally distributed actin filaments and other membrane 
proteins in the apical cell membrane, together with a decreased amount of small 
intestinal microvilli, suggesting a role for K19 in the organization of the apical cell 
membrane (Salas et al. 1997). Smaller microvilli in the small intestine were also 
observed in the plastin-1-/- mouse, where K19 was shown to interact with plastin-1 
for anchoring microvilli to the keratin network (Grimm-Gunter et al. 2009). A 
function for SEKs in colonic stem cells has been shown by K19, where K19-positive 
cells above the crypt base generate radioresistant Lgr5-positive CBC cells (Asfaha et 
al. 2015). An emerging role for colonic keratins in the protection from CRC has 
been established by inflammation-induced tumorigenesis (Misiorek et al. 2016), 
providing one more piece of evidence on the function of intestinal keratins as stress 
modulators and protectors of health. 
Outline and Aims of the Thesis 
28 
OUTLINE AND AIMS OF THE THESIS 
In hepatocytes, K8 has a defined protective role whereas in colonocytes, the role of 
K8 is not yet fully understood. Lack of K8 in mouse colon causes a phenotype 
similar to human IBD. Hepatic, renal, pulmonary and pancreatic keratins protect 
the organ from disease-related stress, while keratin dynamics in intestinal diseases 
are poorly studied. For a better understanding of the roles of colonic keratins, 
colons from K8+/+, K8+/- and K8-/- mice were studied with respect to keratins in 
stress protection and energy metabolism.  
Hypothesis: Keratins play a protective role in the intestinal stress response and in 
the protection from intestinal diseases. 
The specific aims for this thesis were to: 
Aim I.  Analyze colonic keratin levels, localization and phosphorylation using 
colonic disease-related stress and recovery models. 
Aim II.  Investigate the role of keratin levels for colon health by studying the 
susceptibility of K8+/- mice to colitis. 
Aim III.  Investigate changes in the K8-/- colon energy metabolism to understand 
the role of K8 in the colon. 
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EXPERIMENTAL PROCEDURES 
1. Methods 
Selected experimental procedures are described below. Detailed descriptions of all 
the methods and reagents are described in the original publications (I-III). All 
experimental methods used in publications I-III are listed in Table 5. 
Table 5. Methods used in publications I-III 
Method  Publication 
ADP/ATP assay III 
Antibiotic treatment (in vivo) I 
BrDU labelling II 
Confocal microscopy I, II, III 
Coomassie staining II, III 
Cristae quantification III 
Disease activity index (DAI) calculations I 
In vivo DSS colitis I, II, III 
High salt extraction II 
HMGCS2 activity assay III 
Image quantification I, II, III 
Immunofluorescence I, II, III 
Immunohistochemistry II 
In vivo imaging of RONS II 
In vivo ketogenic diet III 
Isolation of lamina propria cells II 
Mitochondria isolation III 
NAD/NADH assay III 
Profiling of fecal bacterial levels III 
Profiling of fecal SCFA levels III 
Quantitative PCR I, II, III 
Screening of K8+/+, K8+/- and K8-/- mice I, II, III 
SDS-PAGE and Western blot I, II, III 
Starvation (in vivo) III 
Statistical analysis I, II, III 
Transfection PhD Thesis 
Transmission electron microscopy III 
Western blot quantification I, II, III 
2D-DIGE III 
1.1 SDS-PAGE, Western Blot and quantification 
Samples for protein analysis of DC/PC, liver, small intestine were suspended in 24 
μl homogenization buffer (0.187 M Tris-HCl pH 6.8, 3% SDS, 5 mM EDTA) per 1 
mg of tissue and homogenized by 75 strokes in a Potter-Elvenhjelm tissue 
homogenizer in order to obtain total tissue lysates. HT-29 or Caco2 cells were lysed 
in homogenization buffer (0.187 M Tris-HCl pH 6.8, 3% SDS, 5 mM EDTA). 
Tissue/cell lysates were incubated at 95°C for 5 minutes and sheared with a 27G 
needle. Protein concentrations were measured with a Pierce BCA protein assay kit 
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(Thermo scientific, Waltham, MA, USA), samples were normalized and 20 μg 
protein per sample was loaded and separated by SDS-PAGE, transferred to a 
polyvinylidene fluoride membrane (PVDF) and further analyzed by Western Blot.  
Membranes were blocked with 5% fat-free milk in PBS-Tween, washed and 
incubated with primary antibody against the protein of interest (Table 6). After 
washing, membranes were incubated with a horseradish peroxidase (HRP)-linked 
secondary antibody (Table 7) raised in the animal corresponding to the primary 
antibody. Chemiluminescence detection of the HRP-conjugated secondary 
antibody was done by enhanced chemiluminescence (ECL). Protein bands were 
quantified with Image J software (National Institutes of Health) and normalized to 
loading control (Hsc70/Actin/Tubulin).  
Table 6. Primary antibodies used in publications I-III. All antibodies, their applications and 
manufacturers used in publications I-III listed. 
Name, clone (if monoclonal) (Manufacturer) Application Publication 
ACC (Cell Signaling technology) WB III 
AMPK-α (Cell Signaling technology) WB III 
AMPK-β1 (Cell Signaling technology) WB III 
Caspase-7 (Cell Signaling technology) WB II 
Cleaved caspase-7 (Cell Signaling technology)  WB II 
COX IV (Cell Signaling technology) WB III 
Cytochrome c (Cell Signaling technology)                    WB III 
Glut4 (Cell Signaling technology) WB III 
HMGCS2 (AVIVA) WB, ICC III 
HMGCS2 (Genway) WB, ICC III 
Hsc70 (Stressgen) WB I, II, III 
HSF2 (Abcam) WB I 
IκB-α (Santa Cruz biotecnology) WB I  
K7, RCK-105 (Abcam) ICC, WB I, II 
K8, Troma I (Hybridoma bank) ICC, WB  I, II, III 
K8, 273 (J. Eriksson) WB, IP I 
K18, Troma II (Hybridoma bank) WB, ICC II 
K18, 275 (J. Eriksson) WB, ICC I 
K19, Troma III (Hybridoma bank) WB, ICC I, II 
K20, IT-Ks 20.10 (Progen) WB, ICC I, II 
K20 (Epitomics) WB, ICC I, II 
MCT1 (Chemicon) WB, ICC III 
MCT1 (Santa Cruz biotechnology) WB, ICC III 
MPO (Thermo Scientific) ICC II 
P-ACC (Cell Signaling) WB III 
P-AMPK-α (Cell Signaling technology) WB III 
P-AMPK-β (Cell Signaling technology) WB III 
P-K8 S74 (M. B. Omary) WB, ICC I 
PPARα (Santa Cruz biotechnology) WB III 
Prohibitin (Abcam) WB III 
α-smooth muscle actin (Abcam) WB III 
β-Tubulin (Sigma) WB II, III 
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Table 7. Secondary antibodies used in publications I-III. All antibodies, their applications and 
manufacturers used in publications I-III listed. 
Name (Manufacturer) Application Publication 
Alexa Fluor 488 (Invitrogen) ICC I, II, III 
Alexa Fluor 546 (Invitrogen) ICC I, II, III 
Alexa Fluor 568 (Invitrogen) ICC I, II, III 
Anti-chicken HRP (Genway) WB III 
Anti-goat HRP (Cell Signaling) WB III 
Anti-mouse HRP (GE healthcare) WB I, II, III 
Anti-rabbit HRP (Cell Signaling) WB I, II, III 
Anti-rat HRP (GE healthcare) WB I, II, III 
1.2 Immunofluorescence staining 
Fresh frozen colon samples in Optimum cutting temperature (O.C.T.) compound 
were cryosectioned (6 μm), fixed in -20°C acetone for 10 minutes and 
immunostained with antibodies (Table 6 and Table 7) as described in (Ku et al. 
2004). HT-29 or Caco2 cells were grown on microscope cover slips and fixed in -
20°C acetone for 10 minutes or 1 % PFA in RT for 20 minutes prior to 
immunofluorescence staining as described in (Ku et al. 2004). Samples were 
analyzed with Leica TCS SP5 matrix confocal microscope (Leica, Mannheim, 
Germany). 
1.3 Experimental in vivo DSS-induced colitis 
1.3.1 Acute DSS colitis 
2-2.5% dextran sulphate sodium (40 kDa, TdB Consultancy AB, Uppsala, Sweden) 
was administered in autoclaved drinking water to 2-3 months old Balb/c or FVB/n 
mice for 7-8 days with or without recovery (7 days) to achieve a model for acute 
colitis (Perse, Cerar 2012, Rose, Sakamoto & Leifer 2012) . Control mice for each 
experiment were age-, sex- and strain-matched littermates, and were treated 
equally as DSS-treated mice, except that they received autoclaved drinking water 
without DSS.  
1.3.2 Chronic DSS colitis 
For mimicking human chronic colitis with alternating relapse and remission, 2-
month-old FVB/n mice were treated one week with 2.5% DSS, followed by a two-
week recovery period after which this cycle was repeated once and the animals 
were sacrificed at day 45 (Breynaert et al. 2013). Control mice for each experiment 
were age-, sex- and strain-matched littermates, and were treated equally as DSS-
treated mice, except that they received autoclaved drinking water without DSS.  
1.3.3 Disease activity index 
A disease activity index (DAI) was used to determine colitis severity. DAI was 
calculated by grading daily measurements starting on day 0 on body weight loss (1 
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point per each 5% of body weight loss), presence of occult blood in stool (0 = none; 
1 = blood in stool pellets; 2 = clotted or fresh blood at anus) and stool consistency 
(0 = normal; 1 = formed but very soft; 2 = slightly loose; 3 = liquid)(Breynaert et al. 
2013). 
1.4 Induction of in vivo ketogenic conditions 
1.4.1 Ketogenic diet 
3-6 months old K8+/+ and K8-/- mice were subjected to ketogenic diet (TD.96355, 
Harlan Teklad Laboratories, Madison, USA) for 3 and 14 days. Corresponding age-
, sex- and strain-matched littermates of K8+/+ and K8-/- mice were subjected to a 
control diet (TD.00606, Harlan Teklad Laboratories, Madison, USA). The 
macronutrient composition of the ketogenic diet (by weight) was: 15.3% protein, 
0.5% carbohydrate and 67.4% fat with energy content of 6.7 kcal/g. The 
corresponding composition of the control diet was: 9.2% protein, 70.9% 
carbohydrate and 5.1% fat with an energy content of 3.7 kcal/g. Since the ketogenic 
diet contains twice as much energy, mice eat a smaller amount of the ketogenic diet 
than the control diet, whereas the intake of protein, minerals and vitamins is 
halved in the ketogenic diet (manufacturer’s suggestion). Cages, water and control 
diet were changed on day 7, and the ketogenic diet was changed on days 1, 2, 4, 6, 
7, 9 and 11. Daily measurements of mouse and food weight as well as blood glucose 
and β-hydroxybutyrate levels were done. Blood glucose and β-hydroxybutyrate 
levels were measured from fresh blood obtained from the submandibular vein 
using goldenrod lancets (Medipoint Inc. NY, USA) using a glucose/β-
hydroxybutyrate meter (Precision Xceed by Abbott Diabetes Care Ltd, Witney, 
UK) on days 0, 3, 7 and 14. The mice were sacrificed by CO2 inhalation on day 14 
and samples from PC, DC, liver and small intestine were collected.  
1.4.2 Starvation 
K8+/+ and K8-/- mice 3 months of age were subjected to 24 hours of starvation with 
unlimited access to water. Weight as well as blood glucose and β-hydroxybutyrate 
levels were measured at 0, 12 and 24 hours after the beginning of starvation. Blood 
glucose and β-hydroxybutyrate levels were measured from fresh blood obtained 
from the submandibular vein using goldenrod lancets (Medipoint Inc. NY, USA) 
using a glucose/β-hydroxybutyrate meter (Precision Xceed by Abbott Diabetes 
Care Ltd, Witney, UK) on days 0, 3, 7 and 14. The mice were sacrificed by CO2 
inhalation on day 14 and samples from PC, DC, liver and small intestine were 
collected.  
1.5 Transfection of Min6-cells 
Murine insulinoma (Min6) cells were grown to 80% confluency, trypsinized, 
washed and diluted in 400μl Optimem. Cells were transfected with or without 0.6 
μg/μl human K8 plasmid + 0.8 μg/μl human K18 plasmid and 5.7 μg/μl MCT1-GFP 
(kind gift from P. Dudeja, University of Chicago) at 220V and 975W. After 
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transfection, cells were plated, grown to 80% confluency on sterile microscope 
cover glasses and fixed in 1% PFA prior to immunofluorescence staining with 
antibodies of interest (Table 5 and Table 6), as described in (Ku et al. 2004). 
2. Mice 
The mice were housed at the Central Animal Laboratory of University of Turku 
(Koe-eläin keskus). The mice were treated according to the approved animal study 
protocol issued by the state Provincial Office of South Finland (licence numbers: 
2007-07005, 2893/04.10.03/2011, 197/04.10.07/2013 and 3956/04.10.07/2016). The 
mice were sacrificed by CO2 inhalation. All mouse strains used in publications I-III 
are listed in Table 8. 
Table 8. Mouse strains used in publications I-III. All mouse strains and their backgrounds used 
in Publications I-III 
Name (background) Publication 
BALB/c I, III 
Human K8 overexpressing mice (FVB/n) PhD Thesis 
K8+/+, K8+/-, K8-/- (FVB/n) I, II, III 
2.1 Screening of K8+/+, K8-/- and K8+/- mice 
K8+/+, K8-/- and K8+/- mice in the FVB/n background were generated by 
interbreeding K8+/- mice or K8+/- females with K8-/- males (Baribault et al. 1994). 
DNA was extracted by lysing the ear piece in 2 mg Proteinase K (Sigma-Aldrich, St. 
Louis, USA)/5 ml Direct PCR lysis reagent (Viagen, Cedar Park, USA) by 
incubation on a 55°C water bath, followed by a 45 min incubation at 85°C. 
Polymerase chain reaction (PCR), consisting of one cycle at 94°C for 10 min, 40 
cycles of 94°C for 45 sec, 70°C for 30 sec, 72°C for 45 sec and one cycle of 72°C for 
10 min, was performed on 2 μl DNA and a mastermix of 2.5μl 5x Phusion HF 
buffer (Thermo Scientific, Waltham, MA, USA), 2μl 10mM dNTPs mix (Thermo 
Scientific, Waltham, MA, USA), 0.3125μl 2U/μl Phusion DNA polymerase 
(Thermo Scientific, Waltham, MA, USA), 1μl 10 ng/μl of each primer (K8-/-
/K8+/+/K8+/- or  K8+/+/K8+/- and K8-/-/K8+/-, Table 9; Metabion, Steinkirchen, 
Germany) and 15.2 μl sterile water. The samples were separated on a 1% agarose 
gel (1% agarose in 0.5xTBE and Midori DNA stain (Nippon genetics, Tokyo, 
Japan) and exposed to UV-light, showing the K8-/- allele (K8-/- and K8+/- primers) at 
800 bp and the K8+/+ allele (K8+/+ and K8+/- primers) at 500 bp (Fig. 7). 
Table 9. Primers used for PCR of K8-/-, K8+/+ and K8+/- genotyping. Used primers and their 
sequences for genotyping of K8-/-, K8+/+ and K8+/- mice. 
Primer Sequence 
K8+/+ 5' CGG TTA GTC GGG AAG AGA GGG GTC 3' 
K8-/- 5' CCT GTC ATC TCA CCT TGC TCC TGC C 3' 
K8+/- 5' TGG GGT TAG GCC CTG CCT CTA GTG TCT 3' 
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3. Cell lines 
All cell lines and their origins used in publications I-III are listed in Table 10.	
Table 10. Cell lines used in publications I-III. Cell lines and their origins used in Publication I-III. 
Name, origin Publication 
HT29, human colorectal adenocarcinoma I, III 
Caco-2, human colorectal adenocarcinoma III 
Min6, murine insulinoma  PhD Thesis 
4. Selected reagents  
Selected reagents and their manufacturers used in publications I-III are listed in 
Table 11. 
Table 11. Reagents used in publications I-III. Reagents and their applications used in 
Publications I-III. 
Name (Manufacturer) Application    Publication 
Acrylaminde (Sigma) SDS-PAGE I, II, III 
ADP/ATP assay kit (Abnova) ADP/ATP ratio assay III 
5-bromo-2’-deoxyuridine (BD biosciences) Proliferation staining II 
Dextran sulphate sodium 40kDa (TdB) Colitis induction I, II, III 
DMEM (Sigma) Cell culture, Caco2 III 
Draq5 (Cell Signaling technology) DNA staining I, II 
Imipenem (Hospira) Antibiotic treatment  I 
KAPA Fast ABI qPCR mix (Kapa biosystems) qPCR reaction I, II, III 
Ketogenic diet (Harlan) Ketogenesis induction III 
L-012 (Wako) In vivo imaging II 
MatriSperse cell recovery (BD biosciences) Crypt isolation III 
NAD/NADH assay kit (Abnova) NAD/NADH ratio assay III 
Pierce BCA protein assay kit (Thermo scientific) Protein assay I, II, III 
RNA later (Qiagen) Sample storage I, II, III 
RNeasy mini kit (Qiagen) RNA isolation II, III 
RPMI-1640 (Sigma) Cell culture, HT-29 I, II, III 
Toto-3 (Life Technologies) DNA staining III 
Vancomycin (Hospira) Antibiotic treatment I 
Figure 7. Genotyping of 
K8+/+, K8-/- and K8+/- mice. 
PCR products from 
extracted mouse DNA was 
run on a 1% agarose gel and 
mouse genotypes were 
determined according to 
primers indicated. Mice # 1, 
2 and 3 were determined by 
2 simultaneous sets of pcr 
with primers for K8+/+/K8+/- 
and K8-/-/K8+/- and while 
mice number 4, 5, and 6 
were determined by one pcr 
with primers for K8-/-/K8+/-
/K8+/+. Final genotypes are: 
Mouse #1= K8+/+, mouse #2 
= K8-/- and mouse #3 = K8+/- 
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RESULTS AND DISCUSSION 
1. Intestinal keratins display a pairwise and context-depending 
upregulation in response to colonic stress and recovery (Publication I) 
1.1 Main colonic keratins K8 and K19 are stress-responsive proteins that are 
upregulated in colonic stress 
The most abundantly found keratins in the colon are K8 and K19, which are 
distributed all over the crypt. The upregulation of type II K8 and its presumable 
type I pair K19 was shown by depleting the colonic pathogenic and non-pathogenic 
microbiota by in vivo murine antibiotic treatment (Publication I, Fig. 4). 
Interestingly, in vivo antibiotic treatment upregulated HSF2 in a similar manner as 
in human ulcerative colitis patients (Miao et al. 2014). The stress-induced 
upregulation of these main colonic keratins was confirmed by in vitro analyses on 
K8/K19 levels in bacterial LPS-stressed HT29 cells (Publication I, Fig. 6). The in 
vitro upregulation of K8 is supported by earlier studies on Bifidobacterium Breve-
induced stress on HT29 cells (Sanchez et al. 2015), by IL-6 treatment on Caco-2 
cells (Wang et al. 2007) and by in vivo LPS-treatment (Dong et al. 2016). By 
treating colorectal cancer cells with LPS, inflammatory TLR4 signaling pathways 
were activated, as confirmed by the decreased levels of the inhibitor of kappa B alfa 
(IκBα) in LPS treated cells (Publication I, Fig. 6). Consequently, a significant 2-fold 
upregulation of K8 on protein level was observed (Publication I, Fig. 6). Colonic 
keratins were mostly upregulated in response to stress, but a slight decrease in 
colonic K8, K18 and K19 was observed in the acute DSS stress models (Publication 
I, Fig 1-2). A similar decrease in K8, K18 and K19 has been observed in human 
ulcerative colitis patients (Corfe et al. 2015), which might be due to a local 
destruction of the colonic single-layered epithelium by DSS. 
The role of K8 and K19 in the tumorigenesis of the colonic epithelium has also 
contributed to the emerging role of SEKs as colonic stress proteins. Several studies 
on human biopsies from colorectal neoplasia suggest that keratin levels are altered 
in carcinogenesis (Evans et al. 2015). A significant downregulation of keratins and 
other cytoskeletal components in tumor tissue together with overexpression of K8 
in the normal mucosa of cancerous tissue was seen when compared to healthy 
controls (Polley et al. 2006). Also, K8-/- mice are known to be more susceptible to 
CRC in response to a chemical and genetic CRC model (Misiorek et al. 2016). 
In other organs where SEKs are present, as for example in the liver, the main 
hepatic keratins K8, K18 (Guldiken et al. 2015a, Szabo et al. 2015) and the newly 
described K23 (Guldiken et al. 2016) were also upregulated in response to induced 
stress both in vivo and in vitro. Renal keratins, K7, K8, K18 and K19 have been 
shown to be stress-responsive in kidney injury models (Djudjaj et al. 2016). The 
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pancreatic keratins, K8, K18, K19 and K20, were similarly overexpressed in 
response to stress and recovery (Zhong et al. 2004, Wogenstein et al. 2014). 
Regarding keratin overexpression beyond SEKs, K6, K16 and K17 have been shown 
to be overexpressed in induced and disease-mediated stress in skin 
(Zhussupbekova et al. 2016, Jin, Wang 2014, Depianto et al. 2010, Freedberg et al. 
2001).  
1.1.1 Colonic K8 S74 phosphorylation is increased in the acute colonic stress 
response 
In a similar way as in liver (Toivola et al. 2004b), kidney (Djudjaj et al. 2016) and 
lung  (Burcham, Raso & Henry 2014) , colonic K8 was hyperphosphorylated at S74 
in response to stress. This was shown for the in vivo acute colitis model 
(Publication I, Fig. 1-2), the microbiota-depleting stress model (Publication I, Fig. 
4) and the in vitro LPS model (Publication I, Fig. 6). Hepatic K8 pS74 has been 
studied in more detail, where this phosphorylation mediates changes in keratin 
solubility, shifting the predominant non-soluble filament state of keratins to a 
more soluble non-filamentous state where keratins appear as dots instead of 
filaments  (Ku, Azhar & Omary 2002, Snider, Omary 2014) . K8 S74 
phosphorylation occurs in mitosis, apoptosis or stress, and it has been suggested to 
protect the tissue from stress by serving as a phosphate "sponge" for stress-activated 
kinases (Ku, Omary 2006). The significantly increased K8 pS74 levels observed in 
the in vitro LPS-treated HT29 cells consisted of equal amounts of mitotic and non-
mitotic cells (Publication I, Fig. 6C-D), while in vivo antibiotic treatment caused 
significantly more K8 proliferating pS74-positive cells compared to non-
proliferating pS74-positive cells (Publication I, SFig. 2). Taken together, main 
intestinal keratins K8 and K19 were shown to act as colonic stress proteins, where 
K8 pS74 serves as a marker of the acute stress response. 
1.2 Type II K7 and type I K20 are increased and differentially distributed in 
response to chronic stress  
1.2.1 Protein levels of K7 and K20 are increased in the colitis stress response 
K7 and K20 were found to be increased in several experimental colitis-stress 
models. The biggest increase in K7 and K20 protein levels was seen after a cyclic 
DSS treatment (chronic DSS), where mice were subjected to DSS for one week, 
followed by a 2-week recovery time. Mice sacrificed at the end of the second 
recovery period displayed a 2-2.5-fold increase in colonic K7 and K20, although no 
changes in mRNA levels were observed at that time (Publication I, Fig. 3). Other 
acute DSS-induced stress models also displayed small, but significant, 
upregulations of K7 and K20 (Publication I, Fig. 1-2). In human colitis, a positive 
correlation between K7 expression and UC has been shown (Stenling et al. 2007, 
Tatsumi et al. 2006). Control patients and patients with inactive colitis lacked 
completely colonic K7, while 90 % of patients with active UC displayed a patchy K7 
expression in the inflamed areas of the colonic epithelium. 
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Altered K7 and K20 expression in colorectal carcinomas has been reported in the 
literature. Increased K20 expression in neoplasia-associated lesions has been 
observed in human colon (Stenling et al. 2007). The present knowledge suggests 
that low or no expression of K7 together with high expression of K20 indicate 
colorectal adenocarcinoma (Chu, Wu & Weiss 2000) . Low K7/high K20 levels are 
also used in the prognosis of Merkel cells carcinomas in skin, while high K7/low 
K20 indicates ovarian-, lung- and breast adenocarcinomas  (Chu, Wu & Weiss 
2000). Nevertheless, together this data implies that these highly disease-responsive 
keratins, K7 and K20, should be considered as stress-responsive proteins. 
1.2.2 K7 and K20 serve as stress-responsive keratins by altering their 
distribution in the colonic stress response 
Colonic K7 and K20 were both significantly increased during chronic stress and in 
the recovery from stress. Their baseline distribution, where K7 is found at the base-
mid crypt axis and K20 at the top brush border (Zhou et al. 2003), was found 
widened after stress conditions. This increased distribution of K7 was seen in 
response to a cyclic chronic DSS-treatment, where K7 was expressed all over the 
crypt and K20 in the top-mid crypt compartment (Publication I, 3D). The same 
was observed in the K8+/- and K8-/- mouse, where a decrease in the overall keratin 
amounts leads to the wider crypt-expression of the remaining K7 and K20 
(Publication II, Fig. 2B). These studies also indicate that the presumable main type 
I partner for K7 in stress situations is K20, since they are both stress-responsive 
keratins upregulated in a similar manner both during chronic DSS treatment and 
in response to the deletion of one K8 allele. The presumable K7-K20 pairing during 
stress in the mid-crypt region was observed by this overlapping de novo expression 
of these keratins, supported by the observation of increased K20 mRNA levels in 
the K7-/- mouse (Sandilands et al. 2013). Since K7 and K20 are not expressed in the 
same cells on the crypt axes during baseline conditions, they are not thought to 
form pairs during normal conditions. In fact, when K18 is knocked out, the levels 
of K7 also dramatically decrease in uterus, bile ducts and kidneys, suggesting that 
K7 is required for K18 stabilization during normal conditions (Magin et al. 1998).  
Except in the chronic colitis-model, K7 and K20 levels also increased in murine in 
vivo senescence (Publication I, Fig. 3D-E and 5D-E). A wider distribution pattern 
of K20 with single-cell K20 positive cells was found in the base-mid crypt 
compartment (Publication I, Fig. 5D-E). In human biopsies from neoplastic areas, 
K20 has been reported to distribute lower down in the crypts when compared to 
biopsies from healthy colon (Stenling et al. 2007). Another piece of evidence 
pointing at K20 serving as a stress-responsive protein is the fact that the K8-/- 
mouse shows a moderate, but not significant, increase in the transcription of the 
K20 gene (Publication II, Fig. 1C), in a similar way as the K7-/- mouse (Sandilands 
et al. 2013). The K7-/- mouse does not display any colonic phenotype, only 
increased proliferation of the bladder urothelium. By challenging the K7-/- mice 
with e.g. DSS, the colonic susceptibility could be addressed in regards of colonic K7 
functions. 
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Stress-induced changes in keratin distribution have also been seen in murine 
pancreatitis, where cytoplasmic K19 and K20 filaments were increased in contrast 
to baseline apical and lateral keratin distribution in acinar cells of the exocrine 
pancreas (Zhong et al. 2004). Similarly, keratins of the renal collecting ducts 
redistributed to a cytoplasmic pattern in response to stress (Djudjaj et al. 2016).  
With all evidence collected from different colonic stress models presented in 
Publication I together with previous publications of SEKs in stress protection, 
intestinal keratins are suggested to be differentially and dynamically upregulated 
and post-translationally modified by phosphorylation in stress and recovery (Fig. 
8). 
	
Fig. 8. Intestinal keratins display a pairwise and context-depending upregulation in response 
to colonic stress and recovery. A summary of Publication I show that during DSS-stress, the K7-
K20 pair is upregulated, while the K8-K19 pair is upregulated in response to the deletion of 
colonic microbiota. Arrows indicate fold-change in keratin expression on protein level. 
2. Decreased K8 levels compromise intestinal stress protection 
(Publication II) 
2.1 50% decrease in K8 render mice more susceptible to colonic stress 
The K8-/- mouse lacks all cytoplasmic K8 and the K8+/- mouse showed an 
intermediate phenotype in regards of keratin levels (Publication II, Fig.1A-B, 2A-
B), crypt length (Publication II, Fig. 3A-B) and abnormal Na/Cl transport (Toivola 
et al. 2004a). In contrast to the K8-/- mouse (Habtezion et al. 2005), the K8+/- mouse 
did not show any signs of spontaneous colitis (Publication II, Fig. 6A-B), defects in 
apoptosis/anoikis rate (Habtezion et al. 2011) or differences in colon length 
(Publication II, Table 1; (Habtezion et al. 2005, Baribault et al. 1994) (Table 12).  
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The K8+/- phenotype with one active allele for K8 reduced K8 levels in colon 
approximately by 50% on both protein and mRNA levels, confirmed by 
immunofluorescence staining. A similar 50% decrease was seen for K7 and K18, 
but only on protein levels (Publication II, Fig. 1). The K8+/- mice showed slightly 
longer crypts (Publication II, Fig. 3) and a wider area of proliferative cells with an 
increased number of 5-bromo-2’-deoxyuridine (BrdU)-positive cells/crypt 
compared to the K8+/+ mouse, even if apoptosis rates were not affected (Publication 
II, Fig. 4).   
When the K8+/- mouse was subjected to acute stress by experimental DSS colitis, 
they were more susceptible to DSS than corresponding K8+/+ mice by displaying a 
higher bleeding score, a higher stool consistency score, a lower body weight % and 
a lower survival score compared to K8+/+ mice (Publication II, Fig. 6A-F). The high 
DAI and slower recovery of K8+/- mice subjected to chronic DSS compared to the 
K8+/+ mice indicate that the K8+/- mouse is more sensitive to DSS-induced colitis 
(Publication II, Suppl. Fig. 3A), supporting the hypothesis of the protective role of 
K8 in intestinal stress and in the recovery from stress. Likewise, the K8+/- mouse 
showed intermediate levels of the Na/Cl transporters AE1/2, ENaC-γ (Toivola	et	al.	
2004a) and DRA (Asghar	 et	 al.	 2016) when compared to K8+/+ and K8-/- colons, 
implicating that lower levels of K8 in the colon are linked to impaired protein 
targeting and function. The permeability of the K8+/- colonocytes did not display 
any changes compared to the K8+/+ phenotype (Misiorek	 et	 al.	 2016), suggesting 
that the lower keratin levels in the K8+/- colon are sufficient for intestinal barrier 
function. Similarly, the 50 % decrease in K8 levels in the K8+/- mouse is likely 
sufficient for protecting from CRC, as the K8+/- mouse did not develop colonic 
tumors in response to a chemical or a genetic tumor model as the K8-/- mouse did. 
However, the levels of the STAT3 regulating protein IL-22BP of K8+/- colonocytes 
showed an intermediate phenotype (Misiorek	 et	 al.	 2016). For future studies, the 
K8+/- mouse, which does not display a baseline colitis phenotype like the K8-/- 
mouse does, might be a more reliable model for studying the protective role of 
keratins in the colon.  
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Table 12. Summary on the K8+/+, K8+/- and K8-/- colonic phenotypes. The K8+/- mouse displays an 
intermediate phenotype in regards of keratin protein levels, crypt length, abnormal Na/Cl 
transport, DRA protein levels and IL-22BP protein levels. In some cases, sufficient protection by 
the intermediate levels of K8 in the K8+/- mice is established (e.g. susceptibility to CRC), whereas 
this is not always achieved (e.g. susceptibility to experimental colitis).  = Increased,  = 
Decreased,  = Unchanged, ND=Not determined. Red arrows indicate intermediate phenotypes 
of the K8+/- mouse.  
Phenotype K8+/+ K8+/- K8-/- Reference 
Keratin protein levels     (Baribault et al. 1994), 
Publication II 
Colon length    Publication II 
Crypt length/hyperproliferation    Publication II 
Epithelial permeability/barrier   / (Misiorek et al. 2016, 
Toivola et al. 2004a) 
Colonocyte apoptosis/anoikis    (Habtezion et al. 2011) 
Spontaneous Th2-type colitis    (Baribault et al. 1994, 
Habtezion et al. 2005) 
Susceptibility to DSS colitis   ND Publication II 
Susceptibility to CRC    (Misiorek et al. 2016) 
Ketogenesis    (Nyström 2013) 
Publication III 
Luminal microbiota  ND  (Habtezion et al. 2011) 
Publication III 
Luminal SCFA levels  ND  Publication III 
MCT1 levels    Publication III(Nyström 
2013) 
Abnormal Na/Cl transport    (Toivola et al. 2004a) 
AE1/2 protein levels    (Toivola et al. 2004a) 
Cl-transporter DRA levels    (Asghar et al. 2016) 
IL-22 mRNA levels    (Misiorek et al. 2016) 
IL-22BP protein levels    (Misiorek et al. 2016) 
P-STAT3    (Misiorek et al. 2016) 
2.2 SEKs can act as partially compensatory keratins during partial K8 deletion 
As a consequence of the deletion of one of the two alleles of K8, K7 and K20 
mRNA levels were not decreased in the K8+/- mouse, although K8 levels were 50 % 
lower at both protein and mRNA levels (Publication II, Fig. 1). This indicates that 
colonic keratins are transcribed independently from each other, and that keratins 
could compensate for each other in the sudden absence of another keratin. 
When K7 was removed, like in the K7-/- mouse, K20 mRNA expression in the 
bladder urothelium was increased, as an expected type I partner (Sandilands et al. 
2013). A small, but not significant, increase in K20 mRNA was also seen in the 
K8+/- mouse colon (Publication II, Fig. 1). The K7-/- mouse did not show an obvious 
phenotype, likely due to the fact that the closely related other type II keratin, K8, is 
present and compensates for K7 (Sandilands et al. 2013). Interestingly, K7 
immunofluorence staining showed a wider distribution in the base-midcrypt 
staining in the K8+/+ to a fainter, but whole crypt staining in the K8+/- and K8-/- 
mouse. This indicates that K7, as the only type II keratin present in the K8-/- mouse, 
compensates for the loss of type II K8 in topmost cells of crypts.  
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3.  K8 deletion leads to a perturbed energy homeostasis and a decreased 
overall energy metabolism in the colon (Publication III) 
3.1  K8 modulates colonic energy metabolism shown by the decreased 
expression of the ketogenic enzyme HMGCS2 in the blunted K8-/- response  
A two-dimensional differential in-gel electrophoresis (2D DIGE) coupled with 
mass spectrometry identified HMGCS2 as one of the major downregulated 
proteins in the K8-/- colonocytes (Publication III, Fig. 1A-B). The most 
differentially expressed proteins in the K8-/- colonocytes were mitochondrial, 
cytoplasmic and endoplasmic reticulum proteins involved in the energy 
metabolism and oxidative stress of the colon. HMGCS2 is the rate-limiting control 
enzyme of ketogenesis, and the downregultion in murine K8-/- colonocytes 
compared to K8+/+ colonocytes was confirmed by (1) protein analysis of in vivo 
colonic crypt lysates (Publication III, Fig. 1C), (2) in vivo total colon lysates 
(Publication III, Fig. 2A) and (3) in two different in vitro small interfering RNA 
(siRNA)-treated cell lines (Publication III, SFig. 1). The enzyme activity of 
HMGCS2 was not affected (Publication III, Fig. 1D-F). Overall mitochondrial 
health was assessed by analyzing proteins involved in energy metabolism, 
suggesting that the mitochondria of K8-/- mice are unaffected by the altered 
phenotype (Publication II, SFig. 6). In addition to that, ultrastructural analyses of 
mitochondria were done, showing, opposite to K8-/- liver mitochondria (Tao et al. 
2009), no changes in colonocyte mitochondrial size but instead fewer cristae per 
mitochondrial section area in K8-/- mice (Publication III, SFig. 5).  
By challenging the colonic ketogenesis by inducing ketogenic conditions in K8-/- 
and K8+/+ mice, the role of K8 was examined. As expected, ketogenic conditions, 
such as starvation and ketogenic diet, upregulated HMGCS2 levels in K8+/+ mice 
(Publication III, Fig. 4A-F). Interestingly, this response was blunted in the K8-/- 
mice, as the K8-/- mouse was not able to significantly increase the HMGCS2 levels 
in response to ketogenic conditions, suggesting a role for K8 in the overall colonic 
energy metabolism.  
Basally ketogenesis and active HMGCS2 are most prominent in the liver, but it is 
also found in the colon, where it is regulated by the availability of microbiota-
produced SCFAs. In the colon, HMGCS2 levels were considerably higher in PC 
compared to DC, likely explained by the higher amounts of microbiota 
(Publication III, Fig. 2A,C). HMGCS2 was not detected in the adult small intestine 
(Hegardt 1999), supporting the hypothesis that K8 plays a role in the energy 
metabolism since the K8-/- mouse does not display any major inflammational 
phenotype in the small intestine (Baribault et al. 1994). The colonic inflammation 
of the K8-/- mouse itself is not the cause of the perturbed ketogenesis, since 
HMGCS2 levels were not decreased in the experimental DSS-colitis setting 
(Publication III, Fig. 2D). The ketogenic conditions clearly affected the liver, since 
blood glucose was decreased and β-hydroxybutyrate was increased in response to 
Results and Discussion 
42 
the ketogenic conditions. However, no differences in these parameters were seen 
between the genotypes (Publication III, Fig. 3A-D). In addition to no observed 
changes in liver HMGCS2 levels during baseline conditions (Publication III, Fig. 
2C), the earlier established roles of K8 in cytoprotection (Omary et al. 2009) and 
altered liver mitochondrial ultrastructure (Tao et al. 2009) in the K8-/- mouse, 
suggests disturbances in liver energy metabolism upon K8 deletion without 
affecting the ketogenic pathway.   
The main transcriptional regulator of HMGCS2 in baseline and ketogenic 
conditions is PPARα. In liver, it has been shown that PPARα manages energy 
stores (Kersten et al. 1999) and increases hepatic HMGCS2 (Rodriguez et al. 1994), 
which is supported by our in vivo colonic data where we showed that PPARα levels 
are mostly following the expression pattern of HMGCS2 (Publication II; Fig 2, 4). 
3.2 Downregulation of the butyrate transporter MCT1 leads to increased 
amounts of luminal SCFAs 
When the decrease of K8-/- colonocyte HMGCS2 was investigated in detail, the 
butyrate transporter MCT1 was also found downregulated. As K8+/+ HMGCS2 
levels were upregulated after starvation, MCT1 levels also increased (Publication 
III, Fig. 5C), suggesting the involvement of MCT1 in the blunted K8-/- ketogenic 
response. HMGCS2 expression is known to be dependent on the colonic 
microbiota and the availability of SCFAs (Cherbuy et al. 2004), and K8-/- mice 
colon is known to be inhabited by fewer microbes than the K8+/+ mice colon 
(Habtezion et al. 2011). Further analyses of the luminal SCFAs and colonic 
microbiota by fecal gas chromatography profiling showed that luminal butyrate 
and isobutyrate levels, the two most prominent of all colonic SCFAs, were 
increased in the K8-/- mice colon although there were no differences in the bacterial 
content between the two genotypes (Publication III, Fig. 6). The main hypothesis 
for the mechanistic role of K8 in the decreased levels of HMGCS2 is that keratins 
contribute to the proper targeting of MCT1 to the cell membrane, supported by the 
fact that the K8-/- mouse exhibits mistargeting and loss of other membrane proteins 
as well (Toivola et al. 2004a, Asghar et al. 2016). 
To analyze the localization of MCT1 in K8-/- conditions a double 
immunofluorescent staining with K8 and MCT1 was done. Although the K8-/- 
colon is hyperproliferative and difficult to analyze, MCT1 was found similarly 
located in the cell membrane of K8+/+ and K8-/- colonocytes, suggesting that MCT1 
localizes to the cell membrane without the help of K8 (Publication II, SFig. 7A). 
However, it is known that in vivo fiber feeding triggers the relocalization of MCT1 
to the apical cell membrane (Borthakur et al. 2012), which was not analyzed here. 
The in vivo double immunofluorescent staining showed a clear lateral staining of 
MCT1 in both K8+/+ and K8-/- colonocytes, supported by several studies showing 
lateral distribution in baseline and starved situations. This in vivo data was 
confirmed by two different in vitro models. First, in K8 siRNA-treated Caco-2 cells, 
MCT1 was also found localized to the cell membrane in a similar way as in control 
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cells (Publication II, SFig. 7B). Similarly, when Min6 cells, which basally lack all 
keratins, were transfected with a plasmid for MCT1-GFP +/- K8/K18, MCT1 
similarly localized to the cell membrane independent of the presence of K8/K18 
filaments (Fig. 9). In both of these K8-/- in vitro models, the decrease in MCT1 
levels was obvious. 
 
Figure 9. MCT1 localization remains unchanged regardless of K8/K18 presence. Confocal 
analyses of Min6-cells transfected with MCT1-GFP plasmid +/- K8/K18 showed no changes in 
MCT1 localization, even if MCT1 levels were decreased in the absence of K8. Green staining 
indicates MCT1, red staining K8/K18 filaments and blue staining cell nuclei. Scale bar = 20 μm. 
Apart from the primary role of MCT1 as an SCFA transporter in colonocytes, 
MCT1 is also involved in the export of the toxic metabolite lactate (Halestrap 
2012). Lactate is produced by glycolysis during the anaerobic breakdown of glucose 
in colonocytes (especially during Warburg metabolism), from where it is 
transported to the liver where it enters gluconeogenesis for glucose production. 
With less MCT1 present in the K8-/- colonocytes, lactate might be accumulated 
inside the cell and influence the overall energy metabolism and acidic content of 
the colonocyte. As a consequence to a blunted pH regulation in the K8-/- 
colonocytes, acidic intracellular content of K8-/- colonocytes has been observed 
(Toivola et al. 2004a). 
MCT1 downregulation as a function of K8 was further confirmed by rescuing the 
K8-/- phenotype. MCT1 levels in mice overexpressing human K8 (hK8) showed 
increased levels of MCT1 together with increased K8 and K19 (Fig. 10). The 
transcriptional regulator of HMGCS2, PPARα, was also found upregulated in this 
model system. Earlier studies have shown that PPARα can directly regulate MCT1 
expression (Konig et al. 2008), therefore also serving as a direct transcriptional 
regulator of MCT1. 
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In conclusion, the results from Publication III show that the decreased amounts of 
the butyrate transporter MCT1 in the K8-/- mouse leads to elevated luminal levels 
of microbiota-produced butyrate. The lower levels of intracellular butyrate feeding 
into the ketogenic pathway leads to decreased levels of HMGCS2, causing an 
overall impaired ketogenesis and energy metabolism in the K8-/- colon, suggesting a 
protective role of colonic K8 in energy homeostasis (Fig. 11). 
	
Figure 11. The K8-/- energy metabolism is decrased in the colon. The ketogenic enzyme 
HMGCS2 is downregulated in the K8-/- colon during baseline conditions, and shows a blunted 
response during ketogenic conditions. When studying upstream regulation of HMGCS2, the 
transcriptional regulator PPARα and the butyrate transporter MCT1 were also found down-
regulated in the K8-/- colon. Therefore butyrate, which was found elevated in the K8-/- lumen, 
cannot enter the colonocytes properly, leading to lower levels of HMGCS2 and a lower amount of 
ketone bodies which are normally used as energy by the colonocytes.  
Figure 10. In vivo overexpression of human 
K8 upregulates colonic MCT1, PPARα, K8 
and K19 in a similar matter. Protein analysis 
showed that by overexpressing human K8 in 
FVB/n mice, the K8-/- phenotype with 
decreased MCT1, K8 and K19 levels was 
rescued. Hsc70 was used as a loading control.  
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4.  Colonic keratins act as stress proteins which are primarily regulated on 
protein level (Publication I, II and III) 
Keratins are primarily upregulated in stress at protein levels, since no increase in 
mRNA levels of stress-induced keratins were seen in any of the stress models used 
in Publication I (Publication I, Fig 1F, 3F and 4D). Similarly, as seen in the K8+/- 
mouse, only K8 mRNA levels were significantly decreased in response to the 
deletion of one K8 allele (Publication II, Fig. 1). mRNA levels of the remaining 
keratins, K7, K18, K19 and K20, were unaltered in this genotype, even if the protein 
levels of K7, K18, K19 and K20 (not significant) were decreased (Publication II, Fig. 
1). The same observation was made in the K7-/- mouse, where only K7 mRNA was 
significantly decreased in the K7+/- mouse (Sandilands et al. 2013), yet another 
piece of evidence indicating that keratin mRNAs are transcribed independently 
from each other.  
No major changes in keratin mRNA levels were observed in any of the used stress 
models in Publication I (Fig. 1, 3, 4) or most of the ketogenic models in Publication 
III (Fig. 4G). In the rapidly renewed colonic epithelium, the overall rate of mRNA-
protein turnover is fast and the time point when protein changes can be detected 
may not overlap with the peak time point for mRNA levels. The same has been 
reported for the downregulation of the Cl-transporter DRA in the K8-/- colon, 
where a total loss of this protein was seen although mRNA levels were unaltered 
(Asghar et al. 2016). Therefore, the situation in the colon is somewhat different 
from that in the liver (Guldiken et al. 2015a) and exocrine pancreas (Zhong et al. 
2004) where keratin overexpression in induced stress has been detected on both 
protein and mRNA levels. Increased mRNA levels were also noted in murine 
diseased kidneys (Djudjaj et al. 2016), although the increase in mRNA levels was 
not proportional to the even higher increase in protein levels in response to stress. 
This suggests the involvement of translational regulation of keratin expression in 
the kidney. However, it is possible that the observed changes in keratin levels could 
be a consequence of protein stability and/or protein degradation, as seen for 
pulmonary K8 and K18 in stress-mediated ubiquitination by the proteasome 
(Jaitovich et al. 2008, Rogel, Jaitovich & Ridge 2010) . In addition, it is known that 
mRNA and protein levels do not always correlate due to post-transcriptional 
mechanisms and different in vivo half-lives of proteins (Greenbaum et al. 2003, 
Chen et al. 2002). More detailed studies about the rather unknown keratin 
transcription factors p53, SP1 and AP1 could also shed some light over the exact 
mechanism for keratin upregulation in stress and recovery (Rhodes, Oshima 1998). 
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CONCLUDING REMARKS 
This thesis shows, by three different murine models, how keratins are modulated in 
stress and in recovery from stress and disease (Fig. 12). Keratins play a role in 
colonic stress protection, shown by: (1) their upregulation after induced stress and 
(2) by the increased susceptibility to experimental colitis when 50 % of K8 is 
removed (K8+/-). (3) When all K8 is removed, the colonic energy homeostasis is 
impaired and blunted, contributing to a disease phenotype. Decreasing keratin 
protein levels cause increased stress sensitivity; two K8 alleles protect from stress, 
one K8 allele causes disease susceptibility and the loss of both K8 alleles causes 
disease (Figure 12 and Table 12). 
Colonic keratins are generally upregulated in response to disease-related stresses in 
a context-dependent matter, demonstrating the stress-responsive nature of 
keratins. During the acute stress response, hyperphosphorylation of K8 occurs, 
which could be used as a marker of acute intestinal disease. The total deletion of K8 
(and the consequent lack of most colonocyte keratins) in mice leads to colitis, and 
mice with 50% less K8 show increased susceptibility to DSS-induced colitis. This 
shows that keratins protect from intestinal stress by being upregulated in response 
to stress.  
The milder K8+/- phenotype is useful for future studies regarding keratins in 
intestinal stress protection, instead of the K8-/- mouse model that exhibits baseline 
colitis or the K8 overexpressing mutant mouse models where the impact of the 
increased keratin levels may be protective.  
	
Figure. 12. K8+/+, K8+/- and K8-/-:  Three models that support the importance of keratins in 
colonic stress protection. The K8+/+ mouse shows a stress-responsive behavior and the increased 
DSS-susceptibility of the K8+/- mice indicates that colonic keratins play an important role in 
protection from intestinal stress. This is further verified by the blunted K8-/- ketogenesis. These 
three mouse models with different amounts of K8 indicate that colonic keratins likely play an 
important role in the protection from intestinal stress. 
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The implication of the results in this thesis on human health reveals the potential 
role of keratins as intestinal disease protectors. The protective role of SEKs in other 
human and murine organs has already been established, whereas the role of 
intestinal SEKs in response to stress has only recently been described. Due to this, 
increased and reorganized intestinal keratins could be considered, similarly as in 
other organs, as markers for stress.  
In conclusion, when normal colonocytes are subjected to stress, keratins are 
upregulated in a context-dependent manner. However, when colonocytes with 
decreased or non-existing keratins are subjected to stress, they develop a more 
severe disease, indicating that colonic keratins are required for intestinal stress 
protection and overall health.	
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FUTURE PROSPECTS 
In regards of intestinal keratins and their role in intestinal stress protection, the 
research focus lies on further analyses on the behavior of colonic keratins in the 
intestinal stress response. Since several keratins respond to murine disease models, 
a specific research direction would be to validate these results in human disease. 
Samples from human intestinal diseases, such as UC, CD and CRC, would be of 
high importance to analyze for keratin expression. Results related to demographic 
information, histologic/endoscopic findings, disease status and medications would 
significantly improve our understanding on how keratins contribute to colonic 
health. Also human colon biopsies from colon tissue subjected to external stresses, 
such as microbiota-depletion by antibiotics or irradiation-mediated intestinal 
damage could be analyzed in regards of a changed keratin profile.  
The role of K8 mutant variants in the pathogenesis of IBD has been identified in a 
few patients, even if a general conclusion about K8 mutations in IBD has not been 
established yet. The current knowledge points to the fact that K8 mutations are 
possibly predisposing factors for the development of IBD. Large studies would be 
needed for further validation of the correlation between keratin mutations and IBD 
in humans. Mouse knock in models expressing human K8 mutations, for example 
the commonly found human mutation G62C, could be used for further analyses on 
human K8 mutations in IBD development. 
Future experiments for investigating the mechanistic and molecular role of 
keratins in stress protection could be done by investigating protein stability by 
different in vitro methods. Another direction for demonstrating a mechanism for 
keratin upregulation in stress would be to collect in vivo samples at different time 
points during stress-experiments, obtaining a time-dependent set of samples which 
could be further analyzed for specific components in affected signaling pathways. 
Studies regarding keratin transcription factors and their regulation could also 
contribute to the understanding of how intestinal keratins protect from stress.  
Another interesting research focus would be to analyze the K8 deletion-mediated 
impaired colonic energy metabolism in regards of keratin levels using the K8+/- 
mouse. Ketogenic conditions could be used for determining if the remaining 
keratin levels in the K8+/- phenotype are able to maintain energy homeostasis in the 
simple-layered epithelia of the colon. 
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